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 White Spot Syndrome Virus (WSSV) is a major pathogen in shrimp 
aquaculture. VP9, a full length protein of WSSV, encoded by ORF WSV230, was 
identified for the first time, in the infected Penaeus monodon shrimp tissues, gill and 
stomach as a novel, nonstructural protein by western blot, mass spectrometry and 
immuno-electron microscopy. Real-time RT-PCR demonstrated that the transcription 
of VP9 started from the early to the late stage of WSSV infection as a major mRNA 
species. The structure of full length VP9 was determined by both X-ray and NMR 
techniques. It represents the first structure to be reported for WSSV nonstructural 
proteins. The crystal structure of VP9 revealed a ferredoxin fold with divalent metal 
ion binding sites. Cadmium sulphate was found to be essential for crystallization. The 
Cd2+ ions were bound between the monomer interfaces of the homodimer. Various 
divalent metal ions were titrated against VP9 and their interactions were analyzed 
using NMR spectroscopy. The titration data indicated that VP9 binds with both Zn2+ 
and Cd2+. VP9 adopts a similar fold as the DNA binding domain of the E2 protein 
from human papillomavirus. Based on our present investigations, we hypothesize that 
VP9 might be involved in the transcriptional regulation of WSSV, a function which is 
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1   Introduction 
 White Spot Syndrome Virus (WSSV) is a major pathogen in shrimp 
aquaculture, causing loss of billions of dollars every year. There is no effective 
treatment for the WSSV infection up to date, thus leading to its prevention and 
treatment being the utmost importance for this disease. The aim of this thesis is to 
provide structural and functional insights into one of the nonstructural viral proteins 
of this pathogen. This study would be valuable in understanding the critical roles such 
as viral transcriptional and host-pathogen interactions. This information obtained will 
thus provide the structural basis for the design of small molecule inhibitors as 
potential drugs to against WSSV infection. 
 
 
1.1  Introduction to virus 
  In 1898, Friedrich Loeffler and Paul Frosch found evidence that the causative 
agent of foot-and-mouth disease in livestock was an infectious particle smaller than 
any bacteria. This was the first clue to the nature of viruses, genetic entities that lie in 
the grey area between living and non-living organisms. 
  Viruses depend on the host cells that they infect for reproduction. When 
found outside of host cells, viruses exist as a protein coat or capsid that sometimes 
enclosed within a membrane. The capsid encloses either DNA or RNA that codes for 
viral elements. When a virus comes into contact with a host cell, it can inject its 
genetic material into its host cells, taking over the host's replication machinery and 
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other cellular activities. An infected cell often produces more viral proteins and 
genetic materials than its usual products. Some viruses can remain dormant inside 
host cells for a long period of time, causing no obvious change in their host cells (a 
stage known as the lysogenic phase). But when a dormant virus is stimulated, it can 
enter the lytic phase where new viruses are formed, self-assembled, rupturing the host 
cell and eventually killing the host cell before infecting other cells (Emiliani, 1993). 
  Viruses are ubiquitous and abundant in nature and can infect and parasitize 
all living organisms from bacteria to mammals. They are considered to be simple 
biological entities composed of a small number of macromolecules produced by, and 
thus derived from, the organism they infect. There are more than 3000 families of 
viruses. Viruses can differ greatly in their physical form. They can be round, 
string-like, or can even resemble an elegant snow-crystal as does adenovirus. A 
feature shared by all viruses is their highly compact structure. There is also a great 
variability in the make up of their genome. Their genome can be RNA or DNA, single 
or double stranded, positive or negative sense, monomeric or dimeric (or fragmented ), 
naked or in complex with proteins. The genomes of two related viruses can 
complement each other through structural, enzymatic and parasitic functions, thus 
contributing to augment virus diversity. This notion of viral diversity by 
trans-complementation within a virus population is important to our understanding of 
viral dynamics and should always be kept in mind when studying single molecular 
clones of a given virus or a part of it (Jean-Luc DARLIX et al., 2005).  
  The gene products of viruses generally are comprised of structural proteins 
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(SPs), which are the components of virus particles and nonstructural proteins (NPs), 
which act as regulators or cofactors controlling the viral infection process. 
 
 
1.2  Introduction to crustacean virus  
  The first report of a crustacean virus was in the crab Macropipus depurator 
by Vago in 1966 (Vlak et al., 2004). Crustacean viruses are currently known to consist 
of a wide range of viral families, including Baculoviridae, Birnaviridae, Bunyaviridae, 
Herpesviridae, Piconaviridae, Parvoviridae, Reoviridae, Rhabdoviridae, Togaviridae, 
Iridoviridae, Nodaviridae and Nimaviridae. Crustacean viral diseases listed by the 
OIE (Office International Des Epizooties; the World Organization for Animal Health) 
include Taura Syndrome (TS), White Spot Disease (WSD), Yellowhead Disease 
(YHD), Tetrahedral Baculovirosis (Baculovirus penaei [BPV] infection), Spherical 
Baculovirosis (Penaeus monodon-type baculovirus [MBV] infection), Infectious 
Hypodermal and Haematopoietic necrosis (IHHN) and Infectious Myonecrosis (IMN). 
Spawner-isolated Mortality Virus Disease (SMVD) was removed from the OIE 
Aquatic Animal Health Code (2005) because the etiology is not well defined. 
Infection with Mourilyan Virus (MoV), White Tail Disease (WTD), and 
Hepatopancreatic Parvovirus (HPV) are listed as emerging diseases (Vlak et al., 
2004). As a crustacean virus, WSSV (Family: Nimaviridae, Genus: Whispovirus) is 
very unique because its infection strategy does not match the infection models of any 
other known virus (Lo, 2005).  
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1.3  Introduction to WSSV 
1.3.1  Background 
  As seafood is a much desired delicacy around the globe, large scale 
production of shrimps has become a major industry worldwide. Intensive cultivation 
of shrimp as well as breeding of shrimps under artificial conditions, e.g. temperature 
control and high population density, provide an ideal environment for the propagation 
of viral pathogens. The situation is worsened by the worldwide trade of the life-stock 
of shrimp, which tremendously facilitates the spread of these pathogens. One of the 
most serious pathogens that causes mass mortality in shrimp is the White Spot 
Syndrome Virus (WSSV) (Wang et al, 1999). The total economic loss due to WSSV 
has averaged more than billions of U.S dollars per year. 
  WSSV not only infects shrimp species such as Penaeid monodon, but also 
many other species of crustaceans including crab and crayfish (Wang et al., 1999). 
The disease typically occurs in juvenile shrimp but sometimes manifests itself in later 
adult stages. Clinical signs include white spots on the shell from abnormal deposits of 
calcium salts, and occasionally a reddish discoloration due to expansion of cuticular 
chromatophores. When farmed shrimps are infected, they become lethargic, stop 
feeding, swim slowly near the pond surface and eventually sink to the bottom and die. 
  WSSV-positive shrimps are now routinely found in the U.S. retail markets 
(Donald 1999) and also in the Singapore markets based on our testing (unpublished 
data). With the information to-date, WSSV does not appear to endanger human health 
(Donald 1999). 
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1.3.2  Structural features of WSSV 
  The WSSV virion is a nonoccluded and enveloped particle (Figure 1.1) of 
approximately 275 by 120 nm with an olive-to-bacilliform shape. It has a 
nucleocapsid (300 by 70 nm) with periodic striations perpendicular to the long axis 
(Wang et al., 1995; Wongteerasupaya et al., 1995). The most prominent feature of 
WSSV is the presence of a tail-like extension at one end of the virion (Durand et al., 
1997; Wongteerasupaya et al., 1995) which gives this virus the family name 
Nimaviridae ("nima" is Latin for "thread") (Mayo, 2002). With a genome size of over 
300 kbp, WSSV is the largest animal DNA virus sequenced to date and second in size 
after Chlorella virus PBCV-1 (331kbp) (Li et al., 1997).   
 
1.3.3  Classification of WSSV 
  Since most of the putative WSSV ORFs bear no homology with known genes 
in the GenBank, the International Committee on Taxonomy of Viruses approved a 
proposal to erect WSSV as the species of the genus Whispovirus, family Nimaviridae 








1.4  Research progress of WSSV 
1.4.1  Sequence determination and analysis 
  The complete genome sequences of three WSSV isolates have been 
determined (Yang et al., 2001) and 181 open reading frames (ORFs) which encode 
more than 60 amino acids long have been identified (Figure 1.2). These analyses were 
consistent among the three isolates from different geographical regions (Yang et al., 
2001; Hulten et al., 2001; Leu et al., 2005). All the three WSSV isolates that have 
been sequenced contain a genome of about 300 kb, and genetic comparisons have 
shown a high degree of genetic similarity (Marks et al., 2004). Homology searches 
against sequence databases suggested possible functions for only a few of these ORFs 
and most of them shown no significant similarity to any other known proteins.  
 
1.4.2  Viral proteins identification 
  The availability of the complete WSSV sequence facilitated the global 
molecular characterization of the virus by genomic and proteomic approaches and has 
recently led to the discovery of many important WSSV genes (Sritunyalucksana et al., 
2006) including latency-associated genes, immediate-early genes, structural genes and 
nonstructural genes. 
 
1.4.2.1  Latency-related genes identification 
  Uninfected shrimp populations are an essential control for the study of 
WSSV infection and they are also generally important in the shrimp industry. 
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However, given the highly infectious nature of WSSV, such populations had been 
historically difficult to establish (Khadijah et al., 2003). Fortunately, 
specific-pathogen-free (SPF) shrimps without WSSV are commercially available 
(BIOTEC, Bangkok, Thailand). These shrimps have been successfully grown for 6 
generations in a well-controlled environment without any disease outbreak. Routine 
diagnosis performed at BIOTEC by using an IQ2000 WSSV detection kit (Farming 
IntelliGen Technology Corporatoin, Taipei, Taiwan) also has confirmed that the 
cultured shrimps were WSSV-free (Lo et al., 1998). However, it has been suggested 
that WSSV could exist in an asymptomatic carrier state. Certain stress conditions such 
as transportation and poor water quality can induce the virus from a carrier state to 
infective state and initiate an outbreak (Tsai et al., 1999). Other researchers have also 
observed the symptoms of WSSV infection in normal shrimps that were thought to 
result from environmental stress rather than viral contamination (Chen et al., 2000; 
Magbanua et al., 2000; Thakur et al., 2002). This raised the question of whether these 
normal shrimps carried the virus in a latent state. Khadijah and his co-workers 
reported for the first time the identification of three WSSV latency-related genes in 
shrimp after comparing the expression of viral gene in WSSV-infected and SPF 
shrimps using DNA microarray technology (Khadijah et al., 2003). A year later, the 
same group further characterized that one of these three genes encoded for a nuclear 




1.4.2.2  Immediate-early (IE) genes identification 
  The expression of viral IE genes depends on the host cell machinery and 
occurs independently of any viral de novo protein synthesis, which means that the IE 
genes are especially important in determining host range (Friesen, 1997). For example, 
during infection by large DNA viruses, such as baculoviruses and herpesviruses, gene 
expression is regulated such that the immediate-early (IE) genes are transcribed first, 
followed by the expression of the early (E) and late (L) genes, respectively (Blissard, 
1996; Blissard and Rohrmann, 1990; Friesen and Miller, 1986; Hoess and Roizman, 
1974). To study the transcription of viral IE genes, viral infection is induced in the 
presence of a protein synthesis inhibitor, usually cycloheximide (CHX), which 
prevents de novo protein synthesis by inhibiting translation. As only translation but 
not transcription of the IE genes is prevented, this blocks the infectious cycle at the IE 
stage. IE genes are rigorously classified as viral genes that are actively transcribed 
during a viral infection in the presence of CHX (Liu et al., 2005). Microarray and 
RT-PCR screening for WSSV IE genes in CHX-treated shrimp has identified a total of 
six potential IE genes. Of which, ie1 showed very strong promoter activity in Sf9 
insect cells using enhanced green fluorescence protein (EGFP) as a reporter (Liu et al., 
2005). It was shown recently that STAT (signal transducer and activator of 
transcription) directly transactivates WSSV ie1 gene expression and contributes to its 




1.4.2.3  Structural genes identification 
  Structural proteins are particularly important in the characterization of any 
virus because they are the first molecules to interact with the host, therefore playing 
critical roles in targeting host cell as well as triggering host defenses (Tsai et al., 
2004). All animal DNA viruses, except poxviruses (Wittek, 1982) and irridovirus 
(Tidona and Darai, 1997) replicate in the cell nucleus (Kasamatsu and Nakanishi, 
1998). In the first step of infection, viruses import their genomic DNA into the nuclei 
of infected cells where the viral proteins are synthesized (Chen et al., 2002). Most 
viruses utilize the nuclear import system of the cell, including microtubules (Sodeik et 
al., 1997; Suomalainen et al., 1999), nuclear pore complex (Greber et al., 1996, 1997), 
receptors and import factors (Marsh and Helenius, 1989; Whittaker and Helenius, 
1998; reviewed in Kasamatsu and Nakanishi, 1998) to access the nucleus. Viruses that 
are too large to easily enter the nucleus will often locate to the nuclear pore to release 
their DNA for transport to the nucleus by associating with one or more mediating viral 
proteins. Examples include canine parvovirus (Vihinen-ranta et al., 2000), Hepatitis B 
virus (Kann et al., 1999), adenovirus (Greber et al., 1997) and simian virus 40 
(Wychowski et al., 1986, 1987; Nakanishi et al., 1996). 
  In the case of WSSV, SDS-PAGE coupled with Western blotting and/or 
protein N-terminal sequencing identified only six structural proteins: VP35, VP28, 
VP26, VP24, VP19, and VP15 (Hameed et al., 1998; van Hulten et al., 2000a; van 
Hulten et al., 2000b; Chen et al., 2002). Recently, a more comprehensive approach 
was available by using a combination of proteomics and mass spectrometry with 
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database searches of sequenced genomes (Liu et al., 2006). The identification of 
WSSV structural proteins is particularly amenable to this approach with the complete 
known genome sequence of WSSV (Yang et al., 2001) and viral particles consist of a 
relatively narrow range of proteins that have constant stable profiles. Due to the 
introduction of proteomic methods, the total number of known WSSV viral structural 
proteins has been increased to 39 (Huang et al., 2002a; Huang et al., 2002b, Li et al., 
2004; Tsai et al., 2004), and Li et al. further increased to 55 (unpublished data). 
However, little is known about the functions of these structural proteins except that 
there was an identification of PmRab that binds directly to VP28 (Sritunyalucksana et 
al., 2006). 
 
1.4.2.4  Nonstructural genes identification 
  Besides structural proteins, nonstructural proteins are also required for 
replication of the viral genome, production of virus particles and inhibition of certain 
host cell functions. These proteins are therefore potential targets for drug design and 
the development of vaccines (Liu et al., 2006). Although considerable progress has 
been made in characterizing the WSSV viral proteins, little attention has been paid to 
nonstructural proteins. To date, reports on the functional characterization of 
nonstructural genes in WSSV are only limited to a few ORFs with high homology to 
ribonucleotide reductase (Tsai et al., 2000), thymidine kinase (TK) and thymidylate 
kinase (TMK) (Tzeng et al., 2002) genes. The functional studies of WSSV proteins 
have been greatly hampered by the lack of a suitable cell line to act as the virus host. 
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FIGURE 1.1 Electron micrographs of purified virions. 
(A) The white outlines indicate (i) a complete mature virion with a characteristic tail, 
(ii) a ruptured mature virion with more than half of the nucleocapsid exposed outside 
of the envelope and (iii) a completely exposed mature nucleocapsid. (B) Immature, 












FIGURE 1.2 Circular representation of the WSSV genome. 
Arrows, positions (outer ring) of the 181 ORFs (red and blue indicate the different 
directions of transcription); green rectangles, 9 hrs. B, sites of BamHI restriction 






 1.5 Introduction to methodology 
  This section gives an overview of the major methods employed in this study 
which include protein purification techniques, real-time RT-PCR, x-ray 
crystallography and nuclear magnetic resonance (NMR). 
 
1.5.1  Protein purification techniques 
  Purification of sufficient amounts of proteins is commonly thought to be one 
of the most important steps in protein research, especially for functional study and 
structure determination. The purity of the protein is always a big concern when 
conducting protein-related researches. Theoretically, proteins can be purified to 
homogeneity by standard chromatographic techniques such as affinity 
chromatography, ion exchange chromatography and gel filtration chromatography. 
The following introduction is adapted from Rajni (2003). 
 
1.5.1.1  Affinity chromatography  
  Affinity chromatography (AF) separates proteins based on reversible 
interaction between a protein and a specific ligand coupled to a chromatographic 
matrix. One of the most common applications of AF is to purify recombinant proteins. 
Proteins that are genetically modified so as to allow them to be selected for affinity 
binding are known as fusion-tagged proteins. Tags include His-tags and GST 
(glutathione-S-transferase) tags. His6-tags have an affinity for nickel or cobalt ions 
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which are covalently bound to NTA (nitrilotriacetic acid). For elution, an excess 
amount of a compound such as imidazole, that is able to act with the nickel ligand, is 
used. GST has an affinity for glutathione, which is commercially available as 
immobilized glutathione sepharose. For elution, excess amount of reduced glutathione 
is used to displace the tagged protein. 
 
1.5.1.2  Ion exchange chromatography 
  Proteins have numerous functional groups that can have both positive and 
negative charges. Ion exchange chromatography (IEC) separates proteins according to 
their net charge, which is dependent on the composition of the mobile phase. By 
adjusting the pH or the ionic concentration of the mobile phase, various protein 
molecules can be separated. For instance, if a protein has a net negative charge at pH 
7, then it will bind to a column of positively-charged beads, whereas a positively 
charged protein would not. The bound proteins can be eluted by decreasing the pH of 
the mobile phase so that the net charge on the protein becomes postive. However, 
elution by changing the ionic strength of the mobile phase has a more subtle effect. 
Ions from the mobile phase interact with the immobilized ligand in preference over 
the bound proteins. This "shields" the stationary phase from the protein, (and vice 
versa) and allows the protein to be eluted. 
 
1.5.1.3  Size exclusion chromatography (SEC) 
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  Size exclusion chromatography (SEC) separates particles based on their sizes, 
or in a more technical term, their hydrodynamic volumes. When an aqueous solution 
is used to transport a sample through a chromatographic column the technique is 
known as gel filtration chromatography. The name gel permeation chromatography is 
used when an organic solvent is used as the mobile phase. SEC is a widely used 
technique for the purification and analysis of synthetic and biological polymers, such 
as proteins, polysaccharides and nucleic acids. The advantage of this method is that 
the various solutions can be applied without interfering with the filtration process, 
while preserving the biological activity of the particles to be separated. 
   
1.5.2  Quantitative real-time RT-PCR 
  The real-time reverse transcription polymerase chain reaction (RT-PCR) 
exploits fluorescent reporter molecules to monitor the production of amplified 
products during each cycle of the PCR reaction. It is one of the technologies of the 
genomic age and has become the method of choice for detection of gene expression at 
the mRNA level. Several factors have contributed to the transformation of this 
technology into a mainstream research tool: (i) as a homogeneous assay it avoids the 
need for post-PCR processing; (ii) a wide (>107-fold) dynamic range allows 
straightforward comparison between RNAs that differ widely in their abundance; and 
(iii) the assay realizes the inherent quantitative potential of the PCR, making it a 
quantitative as well as a qualitative assay. This has resulted in its extensive 
applications in functional genomics, molecular medicine, virology, and biotechnology. 
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  The above introduction is adapted from Bustin (2005). 
 
 
1.5.3 X-ray crystallography 
  Protein X-ray crystallography employs the fact that X-ray can be diffracted 
by protein crystals to discrete patterns. Crystals can be interpreted as an infinite array 
in which building blocks (symmetric units) are arranged according to a well-defined 
symmetry into the unit cell which is translationally repeated in the three-dimensional 
space. Growth of single and well defined diffracting crystals forms the basic and 
essential prerequisite for X-ray crystallography protein structures determination (Blow, 
2002). Producing high quality crystals has always been the bottleneck to structure 
determination, and it is still not understood why some proteins crystallize with ease 
while others stubbornly refuse to produce suitable crystals (Chayen, 2004). It requires 
a protein to be purified to homogeneity and concentrated to a supersaturated state to 
generate crystals. Crystal growth basically takes three steps: nucleation, growth and 
cessation of growth. However, searching for crystallization conditions for a new 
protein has been compared with looking for a needle in a haystack. A major aid is 
using multi-factorial trials. Different techniques are employed for setting up 
crystallization trials which include sitting drop vapor diffusion, hanging drop vapor 
diffusion, sandwich drop and batch, micro batch under oil, micro dialysis and free 
interface diffusion. Although microbatch is the simplest method, it is a relatively new 
technique. Vapor diffusion has been very popular and successful for the past 40 years. 
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Sitting and hanging drop methods are easy to manipulate, require a small amount of 
sample, and allow large amount of flexibility during screening and optimization. Once 
a lead is obtained as to which conditions may be suitable for crystal growth, the 
conditions can generally be fine-tuned by making variations to the parameters 
including precipitant, pH, salt, temperature, etc (Bergfors, 1999). Once good crystals 
are obtained they are harvested either in a capillary or loop and mounted on an X-ray 
source. When a beam of X-ray passes through the crystal they are diffracted in all 
directions and recorded on the X-ray detector with a particular pattern, which is 
known as the diffraction pattern. A number of such diffraction patterns from different 
orientations of the same crystal are recorded to give a data set. The next step is to 
calculate the electron density map so as to ascertain the exact position of each atom in 
the asymmetric unit of the crystal. Calculation of electron density is dependent on two 
main factors; the amplitude and the phase of the diffracted beam. These two factors 
are then Fourier transformed to give the electron density map. The amplitude of the 
beam can be derived from the measured intensity of reflections, but information about 
the phase angle is lost. Due to the lack of phase information in the diffraction pattern, 
direct reconstruction of the electron density of the molecules via Fourier transforms is 
not generally possible. This leads to the so-called phase problem in X-ray 
crystallography. There are a few methods, to date, which can help to circumvent the 
phase problem (Table 1). The actual phase calculation, electron density reconstruction, 
model building, and structure refinement are conducted in silico with computer 





TABLE 1 Phasing methods in protein crystallography 
 
Phasing Method Phasing Marker Derivatization Method Remarks 
SAD via sulfur 
atoms (S-SAD) 
S in Met, Cys, 
residues, combined 
with solvent density 
modification 






Naturally bound metal 
ion, cofactor  
None, native protein  
MAD via Se Se in Se-Met residues Incorporated during 
expression in Met deficient 
cells or via metabolic 
starvation 








Hg, Pt, Au, etc Strong 
signal on L-edges 
SIR(AS) via 
isomorphous metals 
Heavy metal ion 
specifically bound, 













needed back soaking 
necessary 
SIR(AS) via anions Heavy anion 
specifically bound, 
Br_,, I_, 
Mostly brief soaking, or 
co-crystallization 
I derivatives are also 
suitable for Cu source, 
possibly back soaking 
SIR(AS) via noble 
gas 
Noble gas specifically 
bound, Xe, Kr 
Pressure apparatus Xe XAS edge 
unsuitable for most 
MAD beam lines 
MR via model 
structure 
None None Needs a homology 
model with close 
coordinate r.m.s.d. 
Direct Methods None None Atomic resolution, 
small size 
Notes: SAD: Single-wavelength Anomalous Diffraction; MAD: Multi-wavelength Anomalous 
Diffraction; SIR: Single Isomorphous Replacement; MIR: Multiple Isomorphous Replacement; (AS): 







TABLE 2 Computer programs and program packages commonly used in protein 
crystal structure determination 
 
 
Program Website  Functions 
CCP4 Program 
Suite  
www.ccp4.ac.uk Data collection, data processing, phasing, ML 
refinement, model building, validation.  
XPLOR/CNS cns.csb.yale.edu Program pioneering SA and MD in refinement 
of X-ray and NMR data. Complete package 
including phasing and MR 
MOSFLM www.mrc-lmb.cam.ac.uk/h
arry/mosflm
Data image processing, integration, reduction 
and scaling via CCP4. 
HKL2000 
/DENZO 




www.solve.lanl.gov Combined ML HA solution, phasing, 
reciprocal space density modification, NSC, 




www.globalphasing.com ML HA refinement, excellent phasing, density 





Map improvement via dummy atom 





shelx.uni-ac.gwdg.de HA data processing (XPREP), HA 
substructure solution by combined Patterson 
and direct methods, simpler but fast phasing 
and density modification for maps 
BnP www.hwi.buffalo.edu./SnB Direct methods full structure or HA 
substructure solution via reciprocal-direct 
scape cycling 
O alpha2.bmc.uu.se/~alwyn/ Descendant of first generation of pioneering 
graphic modeling programs 






1.5.4  NMR spectroscopy 
 In 1946, Purcell et al. (Purcell et al., 1946) and Bloch et al. (Bloch et al., 
1946) reported for the first time the nuclear magnetic resonance (NMR) phenomenon. 
In 1953, Overhauser defined the concept of nuclear overhauser effect (NOEs), which 
formed the basis for structure determination by NMR. However, only after two 
decades, the first application of NMR in solving protein structure was achieved by 
Ernst and Wüthrich in 1983. Since then, NMR spectroscopy became an alternative 
method to X-ray crystallography for the structure determination of small to medium 
sized proteins (<25 kDa) in aqueous or micellar solutions. The recent progress in 
computational and experimental NMR techniques has improved the efficiency of 
biological NMR research (Bax, 2003). Generally, structure determination by NMR 
involves sample preparation, data acquisition, data processing, data assignments and 
structural calculations.  
 Sophisticated NMR experiments only rarely can compensate for an 
ill-behaved or ill-prepared NMR sample. Accordingly, in nearly all investigations, 
preliminary experiments must be performed to determine sample conditions to satisfy 
the following criteria: (i) the protein must be in a native, functional conformation 
(unless unfolded or intermediate states of protein are of interest; (ii) solubility must be 
sufficient to permit spectra with satisfactory signal-to-noise ratios to be acquired in 
reasonable time periods. Normally, 0.4-0.6 ml of protein solution of approximately 1 
mM concentration is required; (iii) Protein samples used must be free of contaminants 
arising from the NMR tube or the protein preparation. The protein should be 
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monodisperse (unaggregated) at the concentration required for NMR spectroscopy 
and stable for time periods longer than those required for desired NMR experiments; 
(iv) temperature, pH, concentration, and buffer composition affect the solubility, 
aggregation state, and stability of proteins dramatically, and must be optimized 
empirically (Oppenheimer, 1989; Primrose, 1993).  
 A simple one-dimensional proton experiment is the most basic spectrum in 
NMR spectroscopy that can be acquired in a short period of time (usually not more 
than a few minutes) for samples with 0.01 mM concentration and contains great 
amount of information. It is able to show the folding status of the proteins (whether a 
protein is folded or unfolded) which is important for any further functional or 
structural studies on the protein. This is because only folded proteins retain their 
functional activity and three dimensional structures (Rehm et al., 2002). 
Unfortunately, one-dimensional spectra of protein molecules contain overlapping 
signals from many hydrogen atoms because the differences in chemical shifts are 
often smaller than the resolving power of the experiment (Freeman et al., 1962). 
 Due to the greatly improved resolution of two-dimensional experiments, 
these are frequently used for screening and binding studies. The simplest and most 
powerful among them is the heteronuclear single-quantum coherence (HSQC) 
experiment. For this kind of spectrum 15N-labeled protein samples are required. The 
HSQC shows one peak for every proton bound directly to a nitrogen atom and thus 
exactly one signal per residue in the protein (apart from proline residue which is 
devoid of proton bound nitrogen and some additional side chain signals from 
 22
asparagine and glutamine residues which can also be identified). However, 2D NMR 
data is not sufficient to determine the structure of proteins with larger sizes due to the 
overlapping of signals. 
 Given the vast improvement in effective resolution between 1Da and 2D 
NMR spectra, 3D NMR spectroscopy is a logical approach to increase the effective 
resolution still further. The first example of a 3D NMR experiment useful in the study 
of proteins was reported in 1988 (Oschkinat et al., 1988). Heteronuclear 3D 
experiments have tremendously expanded the complexity problems of 2D NMR 
methods (Fesik et al., 1990). The heteronuclear 3D experiments involve at least two 
types of nuclei. It consists of correlating the various nuclei either through scalar 
coupling (COSY, TOCSY, HMQC, HSQC) or through space (NOESY) - spreading 
this crucial (and overlapping) homonuclear information along the X chemical shift 
(either Carbon or Nitrogen) by combining two "classical" 2D experiments (Clore et 
al., 1991). Many choices of 2D or 3D NMR experiments are available for different 
purposes as shown in Table 3. 
 The final result of the sequence-specific assignment of NMR signals is a list 
of distance constraints from specific hydrogen atoms in one residue to hydrogen 
atoms in a second residue. This list immediately identifies the secondary structure 
elements of the protein molecule because both α helices and β sheets have very 
specific sets of interactions of less than 5Å between their hydrogen atoms. It is 
therefore possible to calculate models of the three-dimensional structure of the protein 
(Branden & Tooze, 1999). Eventually, a set of possible structures (usually more than 
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10) rather then a unique structure will be determined.  
 Nuclear magnetic resonance spectroscopy complements X-ray 
crystallography for small and medium size proteins (below 30 kDa) (Montelione et al., 
2000; Prestegard et al., 2001). Its major advantages are that it does not require 
crystals and allows the investigator to study the protein in the solution state. It can 
work in physiologically similar conditions, such as pH, temperature and salt 
concentration, to mimic the in vivo environment, which has been employed in the 
studies of the structure-function relationships (Shuker et al., 1996), comparative 
studies on metabolic pathways from different organisms (Bruggert et al., 2003) and 
identification of binding partners and study of their binding sites (Stoll et al., 2001). It 
was also reported that a series of NMR spectra taken under different conditions can be 
used to monitor aggregation and formation of amyloid fibrils (Zurdo et al., 2001). 
Further, NMR can also be used to investigate dynamics of proteins to distinguish 
multiple conformations (Muhlhahn et al. 1998). Its ability to detect weak ligand 



















1H1H NOESY 2D No NOE constraints and aromatic side chain 
assignment  
1H1H TOCSY 2D No Backbone and side chain assignment 
15N1H HSQC 2D 15N Structural fingerprint studies 
 
Backbone and side chain assignments 
HNCO 3D 15N, 13C Intra-residue for sequential connectivity 
HN(CO)CA 3D 15N, 13C Intra-residue for sequential connectivity 
HN(CA)CO 3D 15N, 13C Intra-residue, used with HNCO 
HNCA 3D 15N, 13C Intra-residue with weaker inter-residue 
correlations between Cα 
CBCACONH 3D 15N, 13C Sequential connectivity and assignment 
HN(CO)CACB 3D 15N, 13C Sequential connectivity and assignment 
HNCACB 3D 15N, 13C Intra-residue with weaker inter-residue 
correlations between Cα and Cβ 
HN(CA)CB 3D 15N, 13C Distinct Ser and Thr 
HA(CACO)NH 3D 15N, 13C, 2H Hα assignment 
HCCH-TOCSY 3D 15N, 13C Side chain assignment 
 3D 15N, 13C, 2H Side chain assignment 
 
Distance NOE measurement and sequential assignments 
15N-edited 
NOESY-HSQC 




3D 15N, 13C, 2H NOE constraints and aromatic side chain 
assignment 
 






1.6  Objectives of this project 
 Structure-based functional analysis is an important approach for elucidating 
the function of proteins. It is of fundamental importance to develop a good expression 
system for unknown proteins to produce a large amount of samples for X-ray, NMR 
and functional studies. These experiments will be the key to a deeper understanding of 
the biology of WSSV, in terms of mechanisms of host-pathogen protein-protein 
interactions, as well as viral assembly. No such analysis has been reported so far for 
the WSSV proteins. Nonstructural proteins are required for the replication of the viral 
genome, assembly of the virus particle and inhibition of certain host cell functions. 
These proteins are therefore potential candidates for drug design and the development 
of vaccines. From many nonstructural proteins in WSSV, viral protein VP9 was 
chosen as the target of this project. This viral protein is coded by ORF wsv230 and it 
is of unknown function and structure. However, its expression during WSSSV 
infection in Penaeid monodon was detected early by RT-PCR. The abundance of this 
protein throughout infection indicated that it might be an important protein (Liu et al., 
2006). Furthermore, it has been reported that VP9 has been patented as a biomarker 
for WSSV infection (Taiwan, 2005). The focus of this project is the structural and 



























  In this chapter, some of the generally-used materials and methods are 
introduced. The rest of the methodologies will be elaborated in the following 
individual chapters. 
 
2.1  Materials 
  All chemicals were of analytical grade and were purchased from Sigma and 
Merck companies, unless otherwise stated. 
 
2.1.1 Enzymes and other proteins 
  Enzymes for molecular biology were mainly purchased from New England 
Biolabs, and other proteins were mainly from Sigma. Refer to appendices for details. 
 
2.1.2  Kit and reagents 
  Kits for molecular biology are mainly from QIAGEN (refer to appendices for 
details).  
 
2.1.3  Media  
2.1.3.1  LB medium 
  One liter LB medium consists of 10 g Bacto-tryptone, 5 g yeast extract and 
10 g NaCl. The pH of the LB medium was adjusted to neutral with 2 N NaOH and 
made up to a final volume of 1 liter with ddH2O. The medium was then sterilized by 
autoclaving (For plates, medium was supplemented with 15 g/l agar and sufficient 
amount of appropriate antibiotics). 
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2.1.3.2 M9 medium 
  One liter M9 medium consists of 7.5 g Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 
1.0 g (NH4)2SO4, 2 g D-glucose, 10 mg thiamine, 10 mg biotin, 2 ml of MgSO4 
solution (1 M), 0.1 ml of CaCl2 solution (1 M), 100 µg ampicillin. It was made up to 1 
L with ddH2O. All chemicals were either sterile filtered or autoclaved.  
 
2.1.4  Stock solutions and buffers 
  All stock solutions and buffers, if not mentioned here, were prepared as 
described by Sambrook and Russell (2001). 
 
2.1.4.1  IPTG stock solution 
  IPTG was dissolved in sterile water to a final concentration of 1 M (2.38 g 
per 10 ml). The stock solution was sterile-filtered and stored in aliquots at –20 °C 
until use. The stock solution was diluted 1:1000 when added to the medium, unless 
otherwise indicated. 
 
2.1.4.2  Ampicillin stock solution 
  Ampicillin was dissolved in sterile water (1 g/ 10 ml) to a final concentration 
of 100 mg/ml. The stock solution was sterile-filtered and stored in aliquots at –20 °C 






2.1.4.3  Buffers for Ni-NTA purification under native conditions 
i. Lysis buffer: 50 mM Tris pH 8.0, 300 mM NaCl, 10 mM β-mercaptoethanol,    
10 mM imidazole, and EDTA-free protease inhibitor cocktail.  
ii. Wash buffer: 50 mM Tris, 300 mM NaCl, 10 mM β-mercaptoethanol, 20 
mM imidazole, pH 8.0. 
iii. Elution buffer: 50 mM Tris, 300 mM NaCl, 10 mM β-mercaptoethanol, 250 
mM imidazole, pH 8.0. 
 
2.1.5  E.coli strains  
  E.coli strains used in this study include DH5α (Invitrogen) and BL21 Star 
(DE3) (Invitrogen).  
 
2.1.6  Plasmid for protein expression 
  Vector used in this study was pET15b (Amersham Biosciences)(Figure 3.1). 
 
2.1.7  NMR chemicals and sample tube 
  All chemicals in NMR studies were purchased from Cambridge Isotope 
Laboratories, Inc., which include Deuterium oxide, D2O (99.99 %), 15N ammonium 
sulfate, (NH4)2SO4 (99.9 %), 13C glucose (99.99 %) and 5 mm emperor thin wall 7740 






2.2  Methods 
2.2.1  Molecular biology techniques (DNA related) 
2.2.1.1  PCR 
  200 – 300 ng of template DNA/cDNA was incubated with a PCR mix with a 
final concentration of 15 pmol of each of the corresponding forward and reverse 
primers, 100 mM of dNTPs, and 1 µl of Pfu DNA polymerase in 1 X pfu buffer made 
up with sterile ddH20 to a final volume of 60 µl. The PCR reaction was then 
performed by thermal cycler under the program of four steps: (i) 94 °C for 2 min; (ii) 
30 cycles of 95 °C for 30 sec, 50 °C for 30 sec and 72 °C for 60 sec; (iii) 72 °C for 15 
min. The parameters are needed to be optimized to overcome nonspecific or 
unsuccessful reactions. 
 
2.2.1.2  Agarose gel eletrophoresis 
  The amplified PCR products were analyzed by agarose gel electrophoresis 
(1.5 % agarose dissolved in TAE buffer containing 10 µg/ml ethidium bromide). 
 
2.2.1.3  PCR products purification 
  Desired PCR amplified products were purified with QIAquick PCR 
purification kit following the manufacturer’s instructions. 
 
2.2.1.4  Enzyme digestion, dephosphorylation and purification 
  10 µl of PCR products or vector pET15b were incubated with 1 µl of 
restriction enzymes in 1X BSA solution and 1X reaction buffer, made to a total 
volume of 20 µl with sterile ddH20 and incubated at 37 °C in a 50 µl reaction for 1-2 
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hours. The restriction digested vectors were then dephosphorylated by treating with 5 
units of calf intestinal phosphates at 37 °C for 1 hour. All reactions were terminated 
by incubation at 85 °C for 20 min. Desired digested products were then excised from 
the agarose gel and purified using QIAquick gel extraction kit following the 
manufacturer’s instruction. 
 
2.2.1.5  Ligation and transformation 
 The mixture of PCR products and the dephosphorylated pET15b vector at a 
ratio of 1:3 to 1:5 was incubated with 3 µL of T4 DNA ligase (400U/µL) at 16 °C 
overnight. The reaction mixture was inactivated at 65 °C for 20 min followed by 
purification. The ligation products were eluted to a final volume of 30 µL with sterile 
Milli-Q water and were ready to be transformed into the competent cell DH5α.  
 100 µl competent cells were thawed on ice before the diluted DNA was 
added. The cells were kept on ice for 30 min. After heat shock at 42 °C for 60 sec, the 
cells were kept on ice for an additional 2 minutes. 800µl LB medium (Amp free) was 
added to the cells and mixed by gently inverting up and down. The cells were then 
incubated at 37 °C for 1 hour before plating onto LB agar plate with 100 µg/ml 
ampicillin. The plates were incubated at 37 ºC until colonies shown. 
 
2.2.1.6  Positive clone screening and plasmid preparation 
  Clones were picked up and incubated in 3 ml LB medium with 100 µg/ml 
ampicillin at 37 ºC for O/N. PCR as well as double enzyme digestion were carried out. 
The products were separated on a 1.0 % agarose gel. The positive clones were 
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selected for plasmid preparation using QIAprep spin miniprep kit following the 
manufacturer’s instructions. 
 
2.2.1.7  Cycle sequencing reaction 
 Cycle sequencing was performed based on the standard protocol supplied by 
Applied Biosystems with minor modifications. The concentration of all the plasmid 
was determined. Cycle sequencing reactions were run on a 96-well PCR plate. Each 
reaction was composed of 2 µL of Terminator Ready Reaction Mix (BigDye™ v3.1), 
3 µL of 5 x sequencing buffer, 3.2 pmol of primer, 300-400 ng recombinant plasmids 
with inserted viral DNA fragment to give a final volume of 20 µL. The entire reaction 
was subjected to 27 cycles of 96ºC for 30 s, 50ºC for 15 s, and 60ºC for 4 min in a 
thermal cycler. The products of the cycle sequencing were transferred to a 1.5 mL 
eppendorf tube and precipitated for 15 min with 80 µL of ethanol/sodium acetate 
solution. The supernatant was carefully removed after 20 min of centrifugation at the 
maximal speed. To remove any trace of unincorporated dye, the DNA pellet was 
washed with 500 µL of 70 % alcohol. After standing for 15 min, the contents of the 
tube were spun down at 13,000 rpm for 5 min. After the supernatant was decanted, the 
tube was inverted and dried overnight at room temperature. 
 
2.2.1.8  Sequence determination  
 Each cycle sequencing product was dissolved in 12 µL Hi-Di formamide and 
mixed with brief vortexing. The tubes containing dissolved DNA fragments were 
transferred to a 96-well sample plate or a PCR plate and covered with a piece of 
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transparent stick tape. After heated at 95 ºC for 2 min, the plate was placed into a 
96-well rack and quickly centrifuged to ensure that the samples were positioned 
correctly at the bottom of the wells. Prior to sequencing, the plate was placed on ice or 
4 °C. The sequencing was carried with ABI PRISMTM 3100 Genetic Analyzer.  
 
2.2.1.9  Transformation 
  The sequence verified plasmids were transformed into BL21 star cells (DE3) 
using the protocol described previously for protein expression. 
 
2.2.2 Protein manipulation techniques 
  VP9 proteins used in this study were all expressed using the E. coli system. 
 
2.2.2.1  Small scale test  
  A small scale test for protein expression is to identify the optimal condition 
for protein production. 5 ml LB containing 100 µg/ml ampicillin was inoculated with 
a fresh single bacterial colony and incubated overnight at 37 °C with vigorous shaking 
(220 rpm) in a 50 ml sterile tube. Pre-warmed 50 ml LB medium in 250-500 ml flask 
was inoculated with 1 ml of the overnight culture, supplemented with appropriate 
antibiotic, and incubated at 37 °C with shaking (180 rpm) until the OD600 reached 0.6 
to 0.8 values. Induction by IPTG with 1 mM final concentration was usually used. 
The cells were then grown for another 2-6 hrs or overnight depending on the 
temperature (15-37 °C). 1 ml of the sample was then taken at regular intervals, the 
cells were pelleted and lysed by sonification, separated on a SDS-PAGE gel and 
visualized by Coomasie Blue staining to examine the levels of protein induction. 
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2.2.2.2  Large scale production of recombinant protein 
  Once the conditions were optimized for protein expression, large-scale 
production of recombinant proteins from E. coli was carried out by culturing cells at 
the previously optimized conditions. 50 ml LB enriched media were inoculated with a 
fresh single bacterial colony and incubated overnight at 37 °C with shaking (220 rpm) 
in a 100 ml flask. For minimal medium, 50 µl culture grown in LB media was used as 
inoculum, instead of a single bacterial colony. 10-15 ml of the overnight culture was 
then pelleted and cells were resuspended in fresh media containing antibiotic and this 
culture was then used to inoculate 1 l flasks with the desired medium containing an 
appropriate antibiotic, which was then incubated at 37 °C with shaking (180 rpm) 
until the OD600 reached 0.7 to 0.8 values (OD was measured using a 
spectrophotometer). Once cells reached the desired OD they were induced with upto 1 
mM IPTG (final concentration). Cells were harvested 3-4 hrs post-induction and 
purified immediately or frozen at -80 °C until further use. 
 
2.2.2.3  SDS-PAGE 
  SDS polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
following Laemmli’s method (Laemmli, 1970). Discontinuous SDS-PAGE with a 
stacking gel (pH 6.8, 0.125 M Tris-HCl, 0.1 % SDS and 5 % acrylamide/Bis solution) 
and a resolving gel (pH 8.8, 0.375 M Tris-HCl, 0.1 % SDS and 15 % acrylamide/Bis 
solution) was performed in 1X SDS running buffer (20 mM Tris Base, 200 mM 
glycine, 0.1 % SDS) at 70 volts for 30 min followed by 200 volts for 30-60 min. After 
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electrophoresis, the gel was stained in the Coomassie staining solution (45 % 
methanol, 10 % acetic acid and 0.25 % Coomassie Brilliant Blue R-250) for 30-60 
min, and then destained with 5 % methanol and 7.5 % acetic acid. 
 
2.2.2.4  Cell storage 
  The cells that express the fusion protein are stored at -80 °C in the LB 
medium with 30-40 % glycerol. 
 
2.2.2.5  Production of polyclonal antibodies  
  To produce specific antibodies against any protein, normally, 2 mg of protein 
will be injected to a 2kg-rabbit for five times with two weeks interval. Finally, the 
serum is purified by agarose A (Roche) using the manufacturer’s protocol.  
 
2.2.2.6 Western blot 
  Two identical SDS-PAGE gels are run side-by-side. One of them was stained 
and used as a control. The other one was placed in the electro-blotting buffer for the 
transfer of the proteins to a nitrocellulose membrane (GE Osmonics Labstore) at 30 
volt for overnight. The nitrocellulose membrane was then blocked with 2.5 % fat-free 
milk with 0.5 % BSA in 1X TTBS buffer for 1 h at room temperature. After that, the 
membrane was washed three times in 1X TTBS buffer. 15 ml of 15,000X diluted 
antibodies was added to the membrane and incubated for 1 h at the room temperature. 
The membrane was then washed three times with 1X TTBS buffer. 10 ml of 5000X 
diluted goat anti-rabbit IgG was added to the membeane. This was washed three times 
with 1X TTBS buffer and stained with the ECL stain (Amersham Biosciences). The 
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film was then developed in the dark room for 5 to 15 minutes depending on the 
background. 
 
2.2.2.7  Silver staining 
  Silver-staining is used to detect proteins with extremely low concentration 
(nanogram range). The procedure is given below.  
(1) Soak gel for 30 min in fixing solution containing 50 % methanol (CH3OH) and 
10 % acetic acid (CH3COOH). Wash gel in water three times for 5 min each. 
(2) Soak gel for 1 min in 0.02 % sodium thiosulfate (Na2S2O3). Wash gel in water 
three times for 20 sec each. 
(3)  Soak gel for 10 min in 0.1 % silver nitrate (AgNO3). Rinse with water three 
times for 1 min each. 
(4)  Soak gel in fresh developing solution (add formalin fresh) containing 3 % 
sodium carbonate (Na2CO3) and 0.02 % formalin (HCHO) until band intensities 
are  adequate (1-3 min). Development continues a little after adding acetic acid. 
(5)  Add 1.4 % EDTA or 5 % acetic acid. Continue shaking for 10 min. Wash gel 10 































  The complete sequence of WSSV has greatly facilitated the molecular 
characterization of this virus and has led to the identification of many WSSV 
structural genes. However studies on nonstructural proteins that are required for the 
replication of the viral genome, the production of the viral particle, and the inhibition 
of the host cell functions are still not available. This report represents the first study 
on a novel WSSV nonstructural protein. 
  In this chapter, molecular cloning, protein expression, and preliminary 
characterization of VP9 will be described. Briefly, gene vp9 was cloned into pET15 
with six histidine residues at the N-terminus and over expressed in the E. coli system 
as a His-tag fusion protein. VP9 was then purified and subjected to biophysical 
characterization prior to functional (Chapter 4) and structural studies (Chapter 5). 
 
 
3.2  Materials and methods 
3.2.1  Materials 
  VP9 specific primers 5’ CGCGCGCATATGGCCACCTTCCAGACTGAC 3’ 
and 3’ CGCGGATCCTTATTCTGTTGTTGGCAC 5’ (underlines indicate the enzyme 
restriction sites) was ordered from 1st Base (Singapore). Nickel-nitrilotriacetic acid 
(Ni2+-NTA) agarose was purchased (Qiagen). Figure 3.1 shows the sequence 





FIGURE 3.1 WSSV VP9 amino acid sequence and expression vector information. 
(A) Single-letter amino acid sequence of VP9 protein of WSSV. (B) The pET-15 
vector carries an N-terminal His-Tag sequence followed by a thrombin site and three 
cloning sites, with unique sites shown on the circle map. (C) pET-15b 
cloning/expression region. Nde I and BamH I are selected for cloning plasmid 




3.2.2  Construction of the expression plasmid 
  The full length DNA coding sequence (residues 1-82) of VP9 was amplified 
by PCR from the purified WSSV virion and the PCR products were further cloned 
into the pET15b vector. The sequence was verified by DNA sequencing. The resulting 
construct was transformed into E. coli strain BL-21 (DE3) for protein expression. 
 
3.2.3  Expression and purification of VP9 
  Initial small scale test indicated that VP9 was a soluble protein. Subsequently, 
large scale expression of VP9 was carried out following the protocol mentioned in 
Chapter 2. The transformed cells were cultured in LB with 100 µg/ml of ampicillin, 
and 1 mM IPTG was added when OD600 value of cells reaches 0.6-0.8. After 
subsequent culture at 37 °C for another 4-5 hours, the cells were harvested by 
centrifugation at 6000 rpm for 30 min and kept at -20 °C prior to purification (Refer 
to Chapter 2 for details). 
  VP9 was purified under native conditions by Ni-NTA chromatography (AF) 
following the manufacturer’s protocol (Qiagen). The cells were lysed by sonication 
followed by centrifugation at 18,000 rpm at 4 ºC for 30 min. The supernatant of the 
lysate was loaded onto Ni-NTA resin, which was pre-equilibrated with at least 5 
column volume of the lysis buffer, with gently shaking for 60 min at 4 °C. The 
VP9-bound resin was then washed substantially and eluted with the elution buffer 
(chapter 2) containing 250 mM imidazole. For structural study of VP9, his-tag was 
cleaved off by thrombin. Basically, after washing of VP9-bound resin, thrombin 
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(100-200 units per 2 mg protein) was added to the resin to cleave the His-tag. The 
eluted VP9 fractions from the Ni2+-NTA column were collected and combined for 
further purification. 
  VP9 was further purified using Mono Q ion exchange chromatography. The 
starting buffer contains 20 mM Tris (pH 8.0) and the elution buffer comprised of 20 
mM Tris (pH 8.0) and 1 M NaCl. The eluted VP9 fractions were collected and 
combined prior to size exclusion chromatography (SEC) purification. The combined 
VP9 sample was concentrated to a sample volume of less than 2 ml using a 
concentrator (Millipore, Singapore). Subsequently, SEC was performed using 
Superdex™30 prepgrade (Pharmacia) with the buffer containing 10 mM sodium 
phosphate buffer pH 6.8 and 150 mM NaCl. 
 
3.2.4  Mass spectrometry analysis 
  Protein was desalted using desalting column (Invitrogen) and subjected to 
MALDI-TOF mass spectrometry (Protein and Proteomics Center, Department of 
Biological Sciences, NUS, Singapore) to verify the molecular weight of VP9. 
 
3.2.5  Dynamic light scattering study 
  To assess the homogeneity of VP9, the protein was characterized using 
dynamic light scattering (DLS) with DynaPro instrument (Protein Solutions Inc). The 
concentration of VP9 was adjusted to 1-5 mg/ml range prior to measurement. The 
experiment was conducted at room temperature (20-25 °C) and the data were 
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analyzed using Dynamics 5.0 (Moradian-Oldak et al., 1998).  
 
3.2.6  Circular dichroism study 
  The secondary structure of VP9 was studied by circular dichroism. VP9 was 
prepared in 10 to 20 mM sodium phosphate buffer, pH 6.8. The experiment was 
conducted in the far UV range (190-260 nm) with Jasco spectropolarimetrer J-720. 





3.3.1 Hydrophobicity plot 
  Figure 3.2 showed the hydrophobicity profile of VP9, which was plotted 
using an online software http://www.vivo.colostate.edu/molkit/hydropathy/index.html. 
Kyte-Doolittle scale (Kyte & Doolittle, 1982) was applied for the plot to delineate the 
hydrophobic character of VP9. The terminal regions were relatively hydrophobic and 
the remaining regions of the protein had only two small hydrophobic regions at amino 
acid positions 43-49 and 52-59. This profile indicated that overall VP9 is a typical 
soluble protein. 
 
3.3.2  Protein purification profiles of VP9 
  VP9 was cloned into pET15 vector, expressed as a soluble form, purified 
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with AF, IEC, and SEC to achieve the appropriate homogeneity level for downstream 
studies. As shown in Figure 3.3, the purity of VP9 reaches 90 % after AF and was 
further improved to above 95 % with the use of IEC (Figure 3.3a). The final purity of 
VP9 obtained was to approximately 99 % after SEC gel filtration purification (Figure 
3.3b).  
 
3.3.3  Mass spectrometry analysis 
  The result showed that the molecular weight (M.W.) of VP9 was 9499 Da, 
which matched the theoretical M.W. of 9492.69 Da (Figure 3.4). The sequence here is 
referring to the full length of VP9 (9211.42 Da) plus GSH residues (299.29 Da) at the 
N-terminal, which was left after thrombin cleavage.  
 
3.3.4  Dynamic light scattering study 
  The DLS data showed that VP9 behaved as a 16 kDa protein at the given 
condition, possibly undertaking an equilibrium state between monomer (9 kDa) and 
dimer (18 kDa) (Figure 3.5). 
 
3.3.5  Circular dichroism study 
  The CD spectrum measured in the far UV region (190-260 nm) in 20 mM 
sodium phosphate buffer (pH 6.8) at 25ºC showed that the secondary structure of VP9 
consisted of a mix of α and β structures (Figure 3.6). Interestingly, its secondary 
structure remained nearly unchanged when the pH was dropped from 6.8 to 5.2. 
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However when the pH gradually dropped to below 4.2, this conformation was 
destroyed and this disruption seemed irreversible because only part of the secondary 
structure could refold back (Figure 3.7) when the pH was brought back to 7.2. This 


























FIGURE 3.2 Hydrophobicity plot of VP9 with window size 7.  

















FIGURE 3.3 Purification profile of His-VP9.  
(a) 15 % SDS-PAGE shows the purity of His-VP9 after AF and IEC, respectively. 
Lane M is for protein maker, lane 1 for protein sample after AF purification and lane 2 
for protein sample after IEC purification. (b) Gel filtration profile of His-VP9 on 















FIGURE 3.4 MS result of native VP9.  















FIGURE 3.5 DLS result of VP9.  
The left window showed that in the given solution, VP9 behaves as a 16kDa protein 
possibly undergoing equilibrium between the monomer (9 kDa) state and the dimer 
















FIGURE 3.6 CD result of VP9. 
Spectrum of circular dichroism in the far UV region (190-260 nm) in 20 mM sodium 

















FIGURE 3.7 CD profile of VP9 upon pH changes.  
pH was decreased gradually from pH 6.8, 6.22, 5.23, 4.11, 3.32, 2.33, 1.67, 1.22 and 








3.4  Discussion 
  In this chapter, we have elucidated several biophysical and structural 
properties of VP9 that provide important information for further studies. Results from 
gel filtration (data not shown) and dynamic light scattering indicated that apparent 
molecular mass was around 16 kDa, whereas analytical ultracentrifuge (data not 
shown) measured the apparent molecular mass to be around 11 kDa. These results 
indicated that in solution, VP9 protein might undergo equilibrium between monomer 






































4.1  Introduction 
  Currently there are no approved vaccines or antiviral drugs available to 
prevent and/or treat WSSV infections. A better understanding of the molecular aspects 
of WSSV replication and pathogenesis will be crucial for the development of effective 
vaccines and/or antivirals. 
  A large amount of work has been carried out on the identification and 
characterization of WSSV structural proteins, including envelope and other capsid 
proteins. However, the functions of most WSSV proteins remain unclear, which is 
mainly due to two major reasons: (i) most of the WSSV genes bear poor sequence 
homology with other known proteins, and thus the function of these genes cannot be 
predicted; (ii) a stable cell line capable of culturing WSSV is not available, making 
the cell-based assay impossible. 
  In this chapter, the functional studies of VP9 will be discussed. Multiple 
approaches had been applied to gain a better understanding on the functional nature of 
this viral protein. The goals of the conducted experiments were (i) to examine the 
gene profiling of vp9 at the mRNA level through the real-time reverse transcription 
polymerase chain reaction (RT-PCR); (ii) to reveal the localization pattern of VP9 (VP 
for protein name) by immuno-electron microscopy (IEM) in conjunction with western 
blot analysis; (iii) to identify the binding partners using pull-down assays. 
  A better understanding of viral protein function and structure (Chapter 5) will 
ultimately boost the development of novel treatments and prevention strategies for 
WSSV infections.  
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4.2  Materials and methods 
4.2.1  Material  
  The first strand cDNA synthesis kit and SYBRgreen reagents used for 
real-time RT-PCR were purchased from Invitrogen and Qiagen respectively. Healthy 
crayfishes were purchased locally (Singapore). The gold-labeled secondary anti-rabbit 
antibodies for IEM studies were purchased from Sigma. Other materials were 
described in Chapter 2. 
 
4.2.2  Shrimp infection with WSSV 
  Infected tissue from a Penaeus monodon (P. monodon) shrimp with a 
pathologically confirmed infection was homogenized in TN buffer (appendix) at 0.1 
g/ml. After centrifugation at 10000 rpm for 10 min, the supernatant was diluted to 
1:100 with 0.9 % NaCl and filtered using 0.4 µm filters (Millipore). Aliquots (0.2 ml) 
of the filtrate were injected intramuscularly into healthy shrimps (determined by PCR) 
in the lateral area of the fourth abdominal segment. At various times post-infection, 
specimens were selected at random and their haemolymph was collected and snap 
frozen at -80 °C. 
 
4.2.3  WSSV purification  
  Infected tissue from P. monodon shrimp was homogenized and centrifuged as 
mentioned above. The supernatant was injected (1:100 dilution in 0.9 % NaCl) 
intramuscularly into healthy crayfish Cherax quadricarinatus (Singapore) in the 
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lateral area of the fourth abdominal segment. After four to five days, freshly extracted 
haemolymph from the infected crayfish was layered on the top of a 20-60 % (w/w) 
continuous sucrose gradient and centrifuged at 31,000 rpm (SW41-Ti rotor on 
Beckman ultracentrifuge) for 2 hours at 4 ºC. Virus bands (located at 40-50 % of 
sucrose range) were collected and diluted 1:10 in TNE buffer (appendix) and further 
centrifuged at 31,000 rpm for 1 hour at 4 ºC. The resulting pellets were resuspended 
in the TNE buffer. The purity of WSSV was examined under the transmission electron 
microscope CM 10 (PHILIPS 450K magnification) as described previously (Huang et 
al., 2001). 
 
4.2.4  Real-time RT-PCR  
4.2.4.1  RNA extraction 
  100 µg WSSV-infected shrimp gill or stomach tissues were homogenized in 1 
ml TRIzol reagent and kept at room temperature for 3 min. Following that, 0.2 ml of 
chloroform is added to the mixture and mixed gently before leaving at room 
temperature for 10 min. The samples were then centrifuged at 14,000 rpm for 15 min 
at 4 °C. The upper supernatant was carefully collected and mixed gently with 0.5 ml 
isopropanol. The samples were centrifuged at 14,000 rpm for 10 min at 4 °C after 
incubation for 10 min at room temperature . The RNA pellets were washed with 1 ml 
of 80 % ethanol by vortexing and harvested by centrifuging at 13000 rpm for 5 min at 
4 °C. The RNA pellets were air dried before dissolving in an appropriate volume of 
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Diethylpyrocarbonate (DEPC)-treated water. After measuring the concentration at 
OD260, the samples were stored at -80 °C for future use. 
 
4.2.4.2  Reverse transcription 
  For RT-PCR, total RNA isolates were transcribed into cDNA using the 
SuperScript III 1st Strand Synthesis System (Invitrogen) according to the 
manufacturer’s instructions. A sample mix consisting of 5 µg total RNA, 1 µl random 
hexamers (50 ng/µl), 1 µl dNTP mix (10 mM), and DEPC-treated H2O making up to 
10 µl was prepared. The mixture was then incubated at 65 °C for 5 min and chilled on 
ice for 1 min. A reaction master mix containing 2 µl of 10X RT buffer, 4 µl of 25 
mM MgCl2, 2 µl of 0.1 M DTT and 1 µl of RNAaseOUT was prepared, added to the 
sample mix and mixed well, and then place at room temperature for 2 min. After that 
add 1 µl (50 units) of SuperScript III RT to each tube, mix and incubate at 25 °C for 
10 min. Following that, the tubes were incubated at 42 °C for 50 min and heat 
inactivated at 70 °C for 15 min and chilled on ice. 1 µl RNase H was added to the 
cDNA mixture to remove any remaining RNA present and incubated at 37 °C for 20 
min. The cDNA was stored at -20 °C for further use. 
 
4.2.4.3  Real-time PCR  
  The cDNA obtained was diluted 10 times for realtime RT-PCR reactions. 
Each cDNA sample, equivalent to 50 ng of total RNA, was then used in the real-time 
RT-PCR reaction. The primers specific for the various genes examined are shown in 
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Table 4. Real-time RT-PCR conditions were optimized by adjusting the annealing 
temperature. PCR was performed using a Light Cycler (Roche Diagnostics) in a total 
reaction mixture of 10 µl containing 1x QuantiTect SYBR Green Master Mix 
(QIAGEN), 0.5 µM of each primer and 25 ng of cDNA. After initial denaturation at 
95 °C for 15 minutes, 40 cycles were performed at 94 °C for 15 seconds, 55 °C for 25 
seconds, and 72 °C for 15 seconds. Melting curve analysis was carried out at 65 ºC for 
15 seconds to verify the specificity of the amplification reaction. Duplicate reactions 
for each specimen were performed. Relative quantification was calculated using the 
∆∆CT and 2–∆∆CT method, where ∆CT refers the difference between the CT values of 
the target gene and the housekeeping gene, β-actin. The CT value is considered as the 
fractional cycle number at which the emitted fluorescence of the sample passes a fixed 
threshold above the baseline. A Tukey’s multiple comparison post-test following 
one-way-analysis of variance (ANOVA) at a 95 % confidence level was performed 
using PRISM version 4.00 for Windows (GraphPad Software).  
 
4.2.5  Localization by Western blot  
  Purified WSSV virions from crayfish Cherax quadricarinatus was further 
separated into envelope and nucleocapsid fractions (Zhang et al., 2004). Briefly, the 
intact WSSV particles were treated with 0.5-1.0 % Triton X-100 at room temperature 
for 30 min. After centrifugation at 119000g for 2 hours using an SW41-Ti rotor 
(Beckman), the pellets were resuspended in 0.1X TNE buffer and centrifuged at 
119000g for 2 hours again. The dissolving and centrifugation step was repeated for a 
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few times in order to remove Triton X-100 completely.  The purity was examined 
using TEM (CM10) before use. 
  Gills and stomachs from moribund crayfish were homogenized separately in 
a lysis buffer (1 % NP-40; 150 mM NaCl, 50 mM Tris pH 8.0, 1 mM DTT, 1 mM 
PMSF). 10 µg of each sample was loaded on to a 10-20 % gradient SDS-PAGE ready 
gel (Bio-rad) followed by Western blot analysis. For western blotting, three antibodies 
used include anti-β-actin, anti-VP28 and anti-VP9. Two identical SDS-PAGE gels 
were prepared and one of them was stained and used as a control. The other gel was 
placed in the electro-blotting buffer (25 mM Tris-HCl, 190 mM glycine, 20 % 
methanol) to transfer proteins to a nitrocellulose membrane (GE Osmonics Labstore) 
at 30 volt at 4 °C overnight. The nitrocellulose membrane was then blocked with 2.5 
% fat-free milk or 0.5 % BSA in 1X TTBS buffer (3 % BSA, 20 mM Tris-HCl, 0.9 % 
NaCl, 0.1 % Tween 20, pH 7.2) for 1 h at 25 °C. Following that, the membrane was 
washed three times in 1X TTBS buffer. Primary antibody at 1:15,000 dilution was 
added to the membrane and incubated for 1 h at 25 °C. The membrane was then 
washed three times with 1X TTBS buffer before adding 1:5000 diluted goat 
anti-rabbit IgG. The membrane was stained with ECL stain (Amersham Biosciences) 
after washing for three times with 1X TTBS buffer. The film (Pierce) was then 
developed in the dark room for 5 to 15 minutes depending on the background signal. 
 
4.2.6  Localization by immuno-electron microscopy 
  The purified WSSV virion suspension and nucleocapsids were mounted onto 
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carbon-coated nickel grids (150 mesh). After incubation at room temperature for 1 
hour, the grids were washed with PBS and incubated with three antibodies including 
anti-VP28, anti-VP664 and anti-VP9 for 1 hour followed by washing with PBS. 
15-nm-gold-labeled anti-rabbit IgG (Sigma) was added to the grids and incubated for 
1 hour. After negatively stained with 2 % phosphortungstic acid, the specimens were 
examined with TEM (CM10).  
  To reconfirm the authenticity of VP9, total tissue lysates were separated by 
performing a 10-20 % gradient gel (Biorad) in parallel with the gel for Western blot. 
A protein band at approximately 9 kDa was found and analyzed with in-gel trypsin 
digestion MALDI TOF-TOF MS analysis as described previously (Song et al., 2004). 
 
4.2.7  Pull down assay 
4.2.7.1  Bait protein preparation 
  VP9 serves as the ‘bait’ to immobilize the interacting proteins in this pull 
down assay thus a sufficient amount of purified bait protein is needed. VP9 was 
expressed as His-tagged protein in E.coli BL-21 for 4½ hrs at 37 °C. The cell 
suspension was spun down at 6000 rpm for 30 min followed by sonication. After 
spinning down at 18000 rpm for 30-45 min at 4 °C, the supernatant containing the 
highly soluble target protein was micro-filtered (0.45µm) (Millipore) to remove the 
trace debris. The pre-equilibrated Ni-NTA Agarose Beads (50µl per 25µg total protein) 
were then added in to the supernatant and washed with abundant buffer and finally 
eluted with buffer containing 250 mM imidazole as similar to native VP9 purification 
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(Chapter 3). Based on the elution profile, the most highly concentrated fractions 
(F1-F5) was combined and concentrated for further purification by gel filtration 
chromatography  
 
4.2.7.2  Prey protein preparation 
  Potential binding partners that originate from the host and the virus itself 
were applied. Samples from haemolymph were extracted from the heart of live shrimp 
and the gill tissue from either of an infected or healthy shrimp was dissected by 
removing the head plate and manually homogenized. One volume of anticoagulation 
buffer (30 mM tri-sodium citrate, 26 mM citric acid, 20 mM EDTA and 15 mM NaCl, 
pH 5.5) was added to the haemolymph from a healthy shrimp to prevent clotting of 
the sample. 
  Five shrimp samples for each group (Table 5) were harvested at the end of 
the third or fourth day after infection and processed immediately. 
 
4.2.7.3  Pull down by Ni-NTA agarose beads 
  The Protein-Protein Interaction kit (ProFoundTM Pull-Down, Pierce) was first 
employed to screen for binding partners of VP9. Following the manufacturer’s 
instructions, the PBS buffer was prepared and then applied to the mini-spin column at 
4 °C overnight. After incubation with potential prey proteins, Ni-NTA agarose beads 
with His-VP9 were washed with buffer, followed by SDS-PAGE analysis. The 
protocol was further optimized by the use of Polyprep columns (BioRad) for more 
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gentle separation of the protein bound beads from the solution. In order to amplify the 
possible signal and therefore enhance the background from SDS-PAGE, an increased 
amount of 100 µl Ni-NTA Agarose Beads (Qiagen) saturated with approximately 
0.5-1 mg of the bait protein (His-VP9) was used. A large volume of prey protein 
sample solution (800 µl) was also applied. With that, a higher amount of the elution 
buffer volume was used.  
 
 
4.3  Results and discussions 
4.3.1  Real-time RT-PCR 
  The vp9 transcript was detected from 2 hours post infection (h.p.i.) while 
dnapol and vp28 (WSSV late gene) were only detected from 10 h.p.i. These results 
indicated that vp9 is an early gene, which might code for a nonstructural protein. The 
level of vp9 transcipt was found to be nearly identical to dnapol or vp28 at 10 to 72 
h.p.i. (Table 6). Statistical analysis (Figure 4.1) using ANOVA showed no significant 
difference (p>0.05) between the transcript levels of vp9 and dnapol or vp28 (except in 
24 h.p.i.) respectively. However at 24 h.p.i, there was a significant increase of vp28 as 
compared to vp9 (p>0.05). This might be due to the large amount of viral particles 
being assembled at this point of post infection time. The transcriptional profile from 
real-time RT-PCR agreed well with the results by western blot, mass spectrometric 
(MS) and immuno-electron microscopy. These experimental evidences strongly 
support that VP9 is a full-length nonstructural WSSV protein with high abundance 
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both at mRNA and protein levels.  
 
4.3.2  Localization 
  Western blot analysis was used to establish VP9 as a non-structural protein. 
This study revealed that the anti-VP9 antibody recognized a protein band of 9 kDa not 
from WSSV virion or uninfected tissues (Figure 4.2 A, B, C) but only from the 
WSSV-infected stomach (Figure 4.2 D) and gills (Figure 4.2 E). Furthermore, 
anti-VP9 antibody failed to recognize VP9 from both envelop and nucleocapsid 
fractions from WSSV virions (Figure 4.2 F, G). This band was analyzed by mass 
spectrometry and its identity was confirmed as VP9 by N-terminal sequencing (Figure 
4.3). The observation that VP9 was detected only from the WSSV-infected tissues but 
not from purified virions was consistent with our immuno-gold labeling experiment 
results, which showed no gold labeling signal by transmission electron microscopy 
(Figure 4.2 H, I, J). As all protein samples were equally loaded and the size of VP9 (9 
kDa) is nearly one third of VP28 (28 kDa), therefore it was suggested that the 
expression level of VP9 protein to VP28 (one of the most abundant viral structural 
proteins) was nearly 1 to 1. These results confirmed that VP9 is a full-length 
nonstructural WSSV protein with high abundance at protein level. 
 
4.3.3  Pull down assay 
  Figure 4-4 shows the protein purification profile of His-VP9 as a bait protein. 
After pull down assay, protein mix was characterized with SDS-PGAE followed by 
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silver staining. Four bands (indicated by arrows) were identified as specific prey and 
were excised and processed for TOF-TOF analysis (Figure 4-5). 
  All samples yielded clear TOF-TOF spectra, though only two (band 1 and 3) 
out of four show significant hits for a database search with in silico digest up to date. 
The database results indicated that the protein band 1 was a hemolymph clottable 
protein precursor with a bit score of 111 (Figure 4.6). The protein band 3 was 
confidently identified as hemocycanin from P. monodon with a bit score of 129 
(Figure 4.7). As WSSV interferes with the blood coagulation mechanism in the 
infected host, a protein-protein interaction between VP9 and these proteins might 
reveal an interesting aspect for future research. All TOF-TOF samples showed 
reasonable spectra, but a database search failed to identify any proteins matching to 
two samples. Considering the unavailability of the complete shrimp EST-database, it 
was speculated that such two proteins were possibly from shrimp instead of WSSV. 
Further data analysis will be attempted once the complete shrimp genome database 
becomes available. 
  For future pull down experiment, however several aspects should be 
considered: (i) the results should be reproducible (e.g. specificity) for each new batch 
of shrimp samples; (ii) a complete cell lysis by sonication should make it more 
accessible to all intracellular proteins; (iii) the use of proteinase inhibitors is necessary 
throughout the experiment to prevent degradation of potential binding partners; (iv) 
high concentration of applied samples will provide a possibility to spot even low 
amounts of binding proteins at SDS-PAGE analysis; (v) protein quantitation of all 
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samples plays a big role in assuring comparability of different samples taken from 










FIGURE 4.1 Transcriptional analysis of WSSV proteins by Real-time RT-PCR.  
In this study relative quantification was calculated using ∆CT, where ∆CT refers the 
difference between the CT values of the target genes and the housekeeping gene 
β-actin. ∆CT value for vp9 (wsv230) is colored in blue, dnapol (wsv514) in black and 













FIGURE 4.2 Localization analysis of VP9 by western blotting and IEM.  
(A) WSSV virions; (B) Non-infected stomach; (C) Non-infected gill; (D) 
WSSV-infected stomach; (E) WSSV-infected gills; (F) Envelope fraction; (G) 
Nucleocapsid fraction; and by immuno-electron microscopy (IEM) using (H) 
anti-VP28 (envelop protein) as positive control, (I) anti-VP664 (nucleocapsid) as 












FIGURE 4.3 Confirmation of molecular weight of VP9 by mass spectrometry.  
Mass spectrometry identified VP9 as a real protein. The band appeared at 9 kDa was 
excised from the gel and subjected to LC-MS/MS analysis. The identified peptide 
sequences were indicated by bold letters (a), which suggested that this protein was the 















TABLE 4 Primers sequences for real-time RT-PCR 
 
Gene Sense Anti-sense 
wsv514 5’TTGAGAGCGATAAGACGGCAA3’ 5’AAGCCATAGCCACGTCCTTTC3’ 
wsv230 5’CCAGACTGACGCCGATTTCTT3’ 5’CGATGCCTCCATTGAGGACAAA3’
wsv421 5’CTTTCACTCTTTCGGTCGTGTC3’ 5’CTCAGCAGTCACAGGAATGCG3’
















TABLE 5 Legend for prey protein samples 
 
code denotation explanation 
HB healthy blood (hemolymph of control group) 
IB infected blood (hemolymph of infected group) 
HT healthy tissue (homogenized gill tissue of control group) 
IT infected tissue (homogenized gill tissue of infected group) 
+ positive control 
 
(without prey protein) 
Æ unspecific binding of E.coli proteins to beads 
- negative control 
 
(without bait protein) 















TABLE 6 Real-time RT-PCR analyses of vp9, vp28 and dnapol from 0 to72 h.p.i 
 
 
Gene of interest h.p.i Gene CT  
values 
β-actin 
CT  values 
∆CT 
0 NC 23.255±0.015 NC 
2 34.950±0.050 25.290±0.310 9.660±0.260
4 37.900±0.300 21.980±0.070 15.920±0.370
6 36.075±0.815 23.920±0.030 12.155±0.845
10 36.110±0.030 25.200±0.370 10.910±0.400
12 34.545±0.635 20.660±0.060 13.885±0.575
24 28.860±0.370 22.795±0.015 6.065±0.355
vp9 
72 12.975±0.635 19.065±0.925 -6.090±0.290
0 NC 23.255±0.015 NC 
2 NC 25.290±0.310 NC 
4 NC 21.980±0.070 NC 
6 NC 23.920±0.030 NC 
10 37.310±3.690 25.200±0.370 12.110±3.320
12 33.740±1.810 20.660±0.060 13.080±1.750
24 24.140±0.370 22.795±0.015 1.345±0.385
vp28 
72 11.340±0.640 19.065±0.925 -7.725±0.285
0 NC 23.255±0.015 NC 
2 NC 25.290±0.310 NC 
4 NC 21.980±0.070 NC 
6 NC 23.920±0.030 NC 
10 34.335±0.245 25.200±0.370 9.135±0.125
12 31.865±0.975 20.660±0.060 11.205±1.035
24 26.845±0.085 22.795±0.015 4.050±0.070
dnapol 






FIGURE 4.4 His-VP9 Bait protein purification profiles.  
(a) 12 % SDS-PAGE shows elution fraction 1 to 10 after Ni-NTA affinity 
chromatography (AC); (b) Elution profile of F1 to F5 from AC (a) by Superdex 30; (c) 








FIGURE 4.5 12 % SDS-Page analysis (maxi-gel) of prey capture (silver stain).  
(M) Marker; (–) negative control using healthy haemolymph; (+) positive control; 
(HB) healthy blood; (IB) infected blood; (IT) infected tissue; volume of elution 










FIGURE 4.6 MS results for protein (band 1).  
(a) indicates that the M.W of protein identified was ~180 kDa; (b) shows the results of 








FIGURE 4.7 MS results for protein (band 3).  
(a) indicates that the M.W of protein identified was ~52 kDa; (b) shows the results of 

























5.1  Introduction 
 
  Though the functional studies (Chapter 4) demonstrated that VP9 maybe an 
important protein based on the transcriptional analysis and localization studies, the 
exact cellular function of VP9 still remains unclear. Structure-based functional 
analysis serves as an important approach for elucidating the function of proteins. 
Currently, the state-of-the-art technologies for protein structure determination include 
X-ray crystallography and Nuclear Magnetic Resonance. Considering that both 
technologies have their own advantages and disadvantages, and they can be 
complementary to each other, both techniques have been employed independently to 
determine the structure of VP9.  
  In this chapter, the structure determination of VP9 by both X-ray and NMR 
will be discussed in detail. 
 
 
5.2  Materials and methods 
 
5.2.1  Materials 
  Isotopic materials for NMR studies were all purchased from Cambridge 
Isotope Laboratories Inc.. The chemicals and reagents for X-ray studies were 
purchased from Sigma, Merck or Hampton research (see Chapter 2 for details).  
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5.2.2  X-ray studies 
5.2.2.1  SeMet VP9 preparation 
  SeMet VP9 was produced using the same bacterial strain grown in M9 
medium, in which 100 mg/L of lysine, 100 mg/L of phenylalanine, 100 mg/L of 
threonine, 50 mg/L isoleucine, 50 mg/L leucine, 50 mg/L valine and 60 mg/L of 
L-selenomethionine was added when OD600 reached about 0.6 to 0.9 (Doublie et al., 
1992). The SeMet VP9 was purified using the same protocol as the native VP9.  
 
5.2.2.2  Crystallization 
  Purified native VP9 was concentrated to approximately 20 mg/ml in a buffer 
consisting of 20 mM Tris pH 8.0, 100 mM NaCl. The protein was crystallized by the 
hanging drop vapor diffusion method at 25 ºC. Initial crystallization screening was 
performed using the sparse matrix approach using kits from Hampton Research 
(Screen I and II). During screening, 1 µl protein solution was mixed with 1 µl 
reservoir solution. The initial condition was further optimized to obtain the best 
diffracting crystals with a reservoir solution consisting of 2 M sodium acetate, 100 
mM MES pH 6.3, 25 mM cadmium sulphate and 3 % glycerol. Crystals grew to 
approximate sizes of ~0.2 X 0.2 X 0.1 mm3 within 7 days.  
 
5.2.2.3  Data collection  
  Prior to mounting, both native and Se-Met crystals were briefly soaked for 
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around 10 seconds in a cryo-protectant solution consisting of a mixture of 50:50 
mineral oil to paraffin oil using a nylon loop and flash cooled at 100 K in a nitrogen 
gas cold stream (Oxford Cryosystems, Oxford, UK). Synchrotron data was collected 
at X12C, beam-line, NSLS, Brookhaven National Laboratory, New York, USA. 
 
5.2.3  NMR studies  
5.2.3.1  Sample preparation 
  15N and 15N/13C-labeled VP9 were prepared in M9 medium with the addition 
of (15NH4)2SO4 for 15N labeling and (15NH4)2SO4 and [13C] glucose for 15N/13C double 
labeling, respectively. The samples for NMR spectroscopy were concentrated and 
dialyzed against 20 mM sodium phosphate buffer with pH 6.8. Typically, the sample 
concentration varied from 0.3 to 1.0 mM. Finally, 450 µl of protein solution was 
mixed with 50 µl of D2O (final concentration is 10 %) and transferred to an NMR 
tube (Cambridge Isotope Laboratories, Inc.). All samples were examined by 15 % 
SDS-PAGE after purification. 
 
5.2.3.2  NMR experiments and data process 
  All NMR spectra were acquired at 298 K on a Bruker 500 or 800 MHz 
spectrometer. 1H-15N-HSQC spectra (Mori et al., 1995) were recorded with 128 
increments in the indirect 15N dimension with scans varying from 4 to 1024 
depending on the concentration of individual samples. Measurement times ranged 
from 2 to 24 hrs. The NMR experiments included 15N-edited HSQC, HNCACB, and 
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CBCA (CO) NH for backbone assignments, 3D-TOCSY, 3D-NOESY and 
HCCH-TOCSY for side-chain assignments. All NMR data were processed with 
NMRPipe (Delaglio et al., 1995) and analyzed with NMRView (Johnson, 2004). 
Structure calculation was performed with the program CYANA (Herrmann et al., 
2002). Distance constraints were obtained from 1H/1H NOEs derived from 15N- 
NOESY and 13C-NOESY spectra. Hydrogen bond restraints were derived from 
HSQC-based hydrogen-deuterium exchange experiment. The phi and psi angle 
constraints were generated from TALOS program (Cornilescu et al., 1999). Ten 
conformers with the lowest final values of the CYANA target function were chosen to 
represent the most probable structures. 
 
5.2.3.3  NMR relaxation studies 
  The understanding of protein function is incomplete without the study of 
protein dynamics. NMR spectroscopy is valuable for probing nanosecond and 
picosecond dynamics via relaxation studies. The use of 15N relaxation to study 
backbone dynamics has become virtually standard (Fischer et al., 1998).  
  The 15N relaxation times T1, T1ρ and 1H-15N NOEs were measured by 
inverse-detected 2D NMR methods (Farrow et al., 1995; Mandel et al., 1996). 
Relaxation time T1 was determined by collecting 8 points with delays of 50ms, 100ms, 
300ms, 500ms, 600ms, 700ms, 800ms and 1s. Relaxation time T1ρ was calculated by 
collecting 8 points with delays of 10ms, 40ms, 70ms, 90ms, 110ms, 130ms, 150ms 
and 160ms. To measure the heteronuclear NOEs, two spectra were acquired with and 
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without proton saturation. All the data were recorded by using 200 and 1024 complex 
points in t1 (1444.8 Hz) and t2 (8012.8Hz) dimensions, respectively. Spin-spin 
relaxation time T2 was calculated from T1 and T1ρ according to the formula below: 
1/ T1ρ = 1/ T1 sin2θ + 1/ T2 cos2θ 
where θ = atan (∆ω/ω1), and ∆ω and ω1 are the resonance offset and spin-lock field 
strength, respectively. Relaxation data were processed and analyzed by the reduced 
spectral density mapping approach.  
 
5.2.3.4  NMR metal titration  
  In order to study the interaction between VP9 and various divalent metals, 
2D 1H-15N HSQC spectra of the 15N-labeled VP9 were measured at a concentration of 
0.1 mM in the absence and presence of divalent metals such as Zn2+, Cd2+, Ca2+ and 
Mg2+. The final ratio of the VP9 to metal was 1:4. The perturbed residues were 
assigned by superimposing the two 15N-HSQC spectra in the absence and the presence 
of different metals. 
 
 
5.3  Results and discussions 
5.3.1  X-ray studies 
5.3.1.1  SeMet VP9 preparation 
  The purity of SeMet VP9 was shown in Figure 5.1. The results indicated that 
SeMet VP9 was pure enough for crystallization.  
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 5.3.1.2  Crystallization  
  Both native and Se-Met substituted VP9 crystals grew under essentially the 
same conditions and both belonged to the same crystal form with similar cell 
parameters. The diffracting crystals are shown in Figure 5.2. 
 
5.3.1.3  Data collection 
  X-ray fluorescence spectra recorded for the crystals of Se-Met VP9 near the 
Se absorption edge were analyzed with the program CHOOCH (Evans et al., 2001) to 
determine correct energies for the measurement of anomalous and dispersive 
differences. Complete MAD datasets were collected at two wavelengths (peak and 
edge) using a Quantum 4 CCD detector (Table 7). Diffraction data were processed 
using the program HKL2000 (Otwinowski et al., 1997). The resolution of the data 
extends up to 3.3 Å. The initial attempts for phase calculation were not successful. 
Since native crystals diffracted better than the Se-Met substituted crystals, a complete 
sulphur SAD data set on the native crystals of VP9 was collected (Table 7). The data 
collected were at the wavelength 1.7 Å with an oscillation of 1.0 degree using a CCD 
detector at a resolution of 2.35 Å. Diffraction data were processed using the program 
HKL2000 (Otwinowski et al., 1997). The crystals belong to the space group P212121 
with a=73.33, b=76.97, c=78.37 Å. A value of VM of 2.9 Å3Da-1 was calculated 
according to Matthews (Matthews, 1968) assuming the presence of four molecules in 
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the asymmetric unit. Based on this calculation the solvent content was estimated to be 
around 57.5 %. Subsequently, a high-resolution dataset was collected up to 2.2 Å 
(Table 7). 
 
5.3.1.4  Structure solution and refinement 
  For phase determination, the resolution range of 2.6 to 20.0Å was chosen. 
During phasing trials, a strong anomalous contribution from Cd2+ was identified with 
appropriate f` and f”. Assignment as Cd2+ was consistent with the high concentration 
of CdSO4 that was essential for crystallization. This interpretation explains why SAD 
phasing around the S absorption edge was unsuccessful due to the weak S signal. 
Initial phase calculations were carried out with SOLVE (Terwilliger, 2002). 
Subsequent heavy-atom refinement and density modification was carried out using 
SHARP (Fortelle et al., 1997). The resulting phase gave an overall figure of merit of 
0.69. The starting electron density map was further improved by phase extension up 
to 2.35Å using the program wARP, which was able to trace the main chain atoms up 
to ~38 % of the model. The remaining parts of the model were built manually using 
the program O (Jones et al., 1991). Further cycles of model building alternating with 
refinement using the program CNS (Brunger et al., 1998) resulted in the final model, 
with an R-factor of 0.225 (Rfree= 0.275) to 2.35Å resolution with no σ-cutoff used 
during refinement. NCS restraints were used only during the initial stage of 
refinement. The final model comprises 316 residues (4 molecules), 8 Cd2+ ions and 
125 water molecules in the asymmetric unit. The first well-ordered residue was Ala2. 
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The last two residues and the first three residues of the linker region could not be 
traced in the electron density map and were not modeled. Validation of the model was 
checked using the program PROCHECK (Laskowski et al., 1993). 
 
5.3.1.5  Crystal structure of VP9 
  The crystal structure of VP9 from WSSV was determined by the single 
wavelength anomalous dispersion (SAD) method from synchrotron data and refined 
to a final R-factor of 0.225 (Rfree=0.275) at 2.35Å resolution (Figure 5.3). The VP9 
model was refined with good stereochemical parameters (Table 7). The asymmetric 
unit consists of four molecules comprising 79 residues each from Ala2 to Thr80 and a 
total of 125 water molecules. The monomer of the VP9 molecule adopts a mixed α/β 
fold with overall dimensions of 32 Å x 25 Å x 20 Å. A total of six β-strands and two 
α-helices are found per molecule. The anti-parallel β-strands β3↑β4↓β2↑β6↓ assemble 
into a single β-sheet (β-sheet I), which forms one face of the molecule. β-sheet II is 
rather small consisting of only two β-strands β1↑β5↓. The two α-helices α1 and α2 
and β-sheet II are packed on the same side of the β-sheet I.  
  In the crystal, dimers of the asymmetric unit are related by a 2-fold 
non-crystallographic symmetry (NCS) approximately parallel to b-axis. Of the eight 
Cd2+ ions of an asymmetric unit, five of them formed an almost perfect tetrahedral 
coordination sphere, whereas the remaining three had five coordinating atoms. In 
every case at least one water molecule was involved in the coordination. In the 
coordination sphere, the distance between the Cd2+ and the coordinating oxygen or 
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sulfur atoms ranged from 1.9 to 2.3 Å. Cd2+ ions coordination were found at the 
monomer interface of the dimer between the side-chains of Asp9, Cys46 of one 
monomer and Glu31 of second monomer of the dimer. These inter monomer 
coordination bonds maintained the rigid architecture of the VP9 dimer. Three Cd2+ 
ions were found to be in the dimerization region of the VP9 dimer. In addition, 
hydrogen bonding and extensive hydrophobic interactions participated in the 
stabilization of the dimer. There are 5 inter monomer hydrogen bonding contacts 
(<3.2 Å). Interactions of the monomers within the dimer mainly comprised of ß-sheet 






















FIGURE 5.1 Final purification profile of VP9.  
Purity of VP9 was characterized by 15 % SDS-PAGE followed by Coomassie Blue 
staining. Lane M, protein markers; (a) Lane 1, purified native VP9. (b) Lane 2, 
purified SeMet VP9. (c) The gel filtration profile of VP9 together with maker proteins. 













FIGURE 5.2 Crystals images of VP9.  









TABLE 7 Data collection and refinement statistics 
Data Set Refinement Phasing 
Cell parameters (Å) a= 74.13, b=78.21, c=78.98 a=73.23, b=76.97, c=78.24 
Space group P212121 P212121 
Data collection 
Resolution range (Å) 2.2-50.0 Å 2.3-50.0Å 
Wavelength (Å) 1.1 1.7 
Observed hkl 249473 214496 
Unique hkl 43491 38474 
Completeness (%) 99.1(2.30-2.2, 95.4 %) 97.4(2.35-2.3, 78.4 %) 
Overall (I/σI) 15.6 17.5 
Rsyma (%) 6.3 5.7 
Refinement 
Resolution range (Å) (I>σ(I) 
Rworkb (no. of reflections) 
Rfreec (no. of reflections) 
RMSD bond lengths (Å) 
RMSD bond angles(deg) 





Average B-factors (Å2) 
Main chain atoms 




Most favored regions (%) 
Additional allowed regions (%) 
Generously allowed regions (%) 






a Rsym = |Ii - <I>|/ |Ii| where Ii is the intensity of the ith measurement, and <I> is the 
mean intensity for that reflection. 
b Rwork = | Fobs - Fcalc|/ |Fobs| where Fcalc and Fobs are the calculated and observed 
structure factor amplitudes, repectively. 











FIGURE 5.3 Ribbon diagram of crystal structure of VP9.  
Two dimers of one asymmetric unit with four cadmium ions (blue spheres) are shown. 
VP9 is shown as ribbons with α-helix in red, β-sheet in cyan and random coil and 






 5.3.2  NMR studies 
 
5.3.2.1  Sample preparation 
  The purity of VP9 samples for NMR studies were characterized by 
SDS-PAGE (Figure 5.4). 
 
5.3.2.2  NMR structure 
 The solution structure of VP9 was also determined by heteronuclear, 
multi-dimensional NMR spectroscopy.  Ten conformers with the lowest target 
function values were chosen to represent the most probable structures from 100 
randomized starting models (Figure 5.5). Assignment of backbone and side-chain 
resonances was accomplished by a combination of double- and triple-resonance 
experiments. Briefly, backbone assignments were complete except for two proline 
residues. More than 92 % of side-chains were assigned. The final NMR structure of 
the full length VP9 was calculated and refined with the CYANA program. This 
calculation was based on manual and auto-assigned 1572 distance restraints (548 
intra-residue, 349 sequential, 212 medium-range and 463 long-range) and 74 
backbone dihedral-angle restraints (Table 8). The Ramachandran map indicated that 
the majority of the residues (84.9 %) had angular averages in energetically most 
favorable regions, 15.1 % in additional allowed regions and none in the generously 
allowed or disallowed regions. 
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 5.3.2.3 NMR relaxation studies 
  Relaxation rate fitting was performed with Matlab6.5 Release 13 (The 
Mathworks, Natick, NJ). The data were shown in Figure 5.6. The results indicated 




























FIGURE 5.4 SDS-PAGE of NMR samples.  
Lane M, protein maker; Lane 1, control; Lane 2, H2O sample without Histag; Lane 3, 
D2O sample without His-tag; Lane 4, 15N/ 13C sample without His-tag; Lane 5, 15N 















FIGURE 5.5 Ribbon diagram of NMR structures of VP9.  
Ten lowest-energy structures of VP9 superimposed as ribbons with α-helix in red, 








TABLE 8 NMR structural statistics 
 
Restraints used in the structure calculation  
  Number of distance constraints   
    Total  1572 
      Intra-residue ( |i-j| = 0 ) 548 
      Sequential ( |i-j| = 1 ) 349 
      Medium range (1 < |i-j| < 5 ) 212 
      Long range (|i-j| >5) 463 
  Number of torsion angle constraints 74 
  Φ 37 
  Ψ 37 
  Number of hydrogen bond restraints 24 
Residual violations in the DYANA calculation  
  Residual DYANA target function value (Å2) 0.45 
Residual NOE distance constraint violations a  
  Number > 0.1 Å 1 
Residual dihedral angle constraint violations a  
  Number > 5.0 degrees 0 
Geometric statistics  
  Average backbone atoms RMSD to mean (Å) b 0.37+0.07 
  Average heavy atom RMSD to mean (Å) b 0.87+0.13 
Ramachandran analysis c  
  Residues in most favored regions (%) 84.9 
  Residues in additional allowed regions (%) 15.1 
  Residues in generously regions (%) 0.0 
  Residues in disallowed regions (%) 0.0 
Ten structures with the lowest CYANA target function are selected out of 100 structures calculated 
using CYANA from randomized staring structures. 
a Constraints violated in beyond five structures. 
b RMSD for residues from 2 to 80. 





FIGURE 5.6 NMR relaxation results.  
15N R1, 15N R2, and heteronuclear NOEs for VP9 (black square). The average T2 of 
VP9 is around 110-120 ms.  
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5.3.3  VP9 interacts with metals 
5.3.3.1  Metal binding sites 
  In the electron density map of the native protein, there were eight strong 
peaks corresponding to metal ions (Figure 5.7). Based on the coordination we have 
interpreted these peaks as Cd2+ ions. It is worth mentioning here that the Cd2+ ions 
were essential for crystallization; these metal ions must have been acquired during the 
crystallization process. The presence of tightly bound divalent metal ions has been 
previously reported for the structural homologs of VP9 (Banci et al., 2002; 
Rosenzweig et al., 1999). 
  It is noteworthy to observe that during crystallization, VP9 was unable to 
crystallize in the absence of Cd2+ and even a reduction of the Cd2+ concentration led 
to the destabilization of crystals, strongly indicating the crucial role of Cd2+ ions to 
form intermolecular contacts for crystal formation (Figure 5.8). Various divalent metal 
ions are integral parts of several viral proteins and are necessary for their survival and 
pathogenesis (Chaturvedi et al., 2005). These bound metal ions are also required for 
nucleocapsid protein-transactivation response (TAR)-RNA interactions. Zinc, is the 
most common divalent metal ion that influences a variety of viral infections 
(Chaturvedi et al., 2005). Proteins from viruses such as HIV-1, Hepatitis C, Hepatitis 
B, Herpes Simplex, Pox, Rubella, Influenza, Corona, Human Papilloma, Ebola, 
Picorn and Rotavirus essentially bind with Zn2+ and carry out the host infection 
respectively (Chaturvedi et al., 2005). In VP9, the observed divalent metal ion 
coordinates with Asp, Glu and Cys. Since there is no histidine and only one cysteine 
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is present in the sequence of VP9, the observed coordinating side-chains could be 
considered as an unconventional binding site for Zn2+. Recently, Wuxian et al (Shi et 
al., 2005) reported a similar unconventional Zn2+ binding site with His, Asp and Glu. 
VP9 has identical coordinating side-chains except that histidine is replaced by 
cysteine. In the crystal, substitution of Cd2+ ions for the natural Zn2+ binding sites has 
been observed. Similar substitutions from the crystallization buffers have been 
previously reported (Shi et al., 2005). In VP9, all the natural Zn2+ binding sites might 
be taken up by the Cd2+ ions present in the crystallization solution. To further verify 






















FIGURE 5.7 Simulated-annealing Fo-Fc omit map in the dimerization region of 
VP9.  All the three cadimum ions (green) and all atoms within 3.5 Å of cadmium 
ions were omitted prior to refinement and map calculation. The map was contoured at 














FIGURE 5.8 Stick representation for the cadmium coordination sphere.  
Yellow dash line indicates the coordination bond. Cd2+ in green and water molecule in 
red respectively. Asp9, Cys46 and Glu31 from one monomer are shown in cyan and 








5.3.3.2  NMR metal titration  
  The results indicated that only Zn2+ and Cd2+ were able to bind with VP9. 
Therefore we have monitored the binding interaction between 15N-labeled VP9 and 
zinc/cadmium. Figure 5.9a shows the binding profiles of VP9 with Zn2+. A detailed 
analysis of the HSQC titration resulted in the identification of 42 perturbed peaks that 
either disappeared or underwent chemical shifts. Peaks disappeared because of NMR 
resonance broadening, indicating that binding led to a significant increase in the 
conformational exchange on the microsecond-millisecond time scale. The pattern for 
cadmium was similar to that of zinc (Figure 5.9b). However there is no detectable 
interaction between VP9 with either magnesium or calcium (data no shown). Our data 












FIGURE 5.9 Dual 1H-15N HSQC spectra of VP9 in the absence (red) and 
presence (blue) of Zn-sulfate (a) and Cd-sulfate (b). Superimposition of the 
1H-15N HSQC spectra of the free form of VP9 in red and in the complex with zinc 
sulfate/cadmium sulfate in blue at a ratio of about 1:4 at pH 6.72 and 298 K. 42 
perturbed peaks that either disappeared or underwent chemical shifts are referring to 
Asn56, Tyr43, Glu31, Glu72, Arg19, Met44, Leu12, Gln74, Val45, Gly50, Gly57, 
Leu11, Leu47, Lys35, Leu55, Glu21, Gly14, Thr6, Ile59, Ser36, Val13, Arg63, Asp40, 
Asp15, Met76, Thr52, Leu48, Cys46, Val78, Ala2, Thr80, Thr81, Ile77, Phe4, Asp7, 
Ala32, Phe10, Asp9, Leu64, Gln5, Glu61, Leu62. Of 42 perturbed peaks, Asp9, Phe10, 
Glu31, Val45, Cys46, Leu47, and Leu48 were perturbed the most due to close 
locations to the metal binding sites. 
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5.3.4  Comparison of crystal structure vs. NMR structure 
  The three dimensional structures of VP9 were independently determined both 
by X-ray crystallography and NMR spectroscopy. The root mean square deviation 
(rmsd) between X-ray and NMR models was ~1.194Å for 74 Cα atoms (Phe4 to 
Thr76), which indicated a good agreement between the two structures (Figure 5.10). It 
is notable that the NMR structure was determined in conditions free of metal ions 
whereas the X-ray structure was determined with Cd2+ ions. The observed metal ions 
were located on the monomer interface of the dimer as well as on the surface of the 
molecule. This suggested that the metal ions were not essential for the folding of VP9. 
The structure of VP9 revealed a ferredoxin fold, a well known nucleotide recognition 
fold. The following structural description is based on the crystal structure.  
 
5.3.5  Sequence and structural homology 
  BLAST search reveals that VP9 has sequence homologies to only a few other 
WSSV proteins of unknown function. It exhibits a maximum identity of 43 % with 
wsv234 and a minimum of 31 % with wsv231 from WSSV. Search for structurally 
similar proteins within the PDB database was performed with the program DALI 
(Holm et al., 1995). Significant structural similarities were found with several 
nucleotide binding and metal transport/binding proteins. The highest structural 
similarity was observed between VP9 and Bovine papillomavirus-1 E2 DNA-binding 
protein (Pdb code 2BOP) yielding an rmsd of 3.0 Å for 63 Cα atoms with 17 % 
sequence identity. This was followed by a metal Transporting ATPase (PDB code: 
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1MWY, rmsd of 2.4 Å for 59 Cα atoms, with 14.6 % identity) and Atx1 
Metallochaperone (PDB code 1CC8; rmsd of 2.6 Å for 62 Cα atoms; 13.4 % identity). 
These structurally homologous proteins were superimposed in O program (Jones et al., 
1991) and their conformational similarities and differences were examined. Except α2 
of VP9 and other small local structural differences, all the secondary structural 
elements were comparable and superimposable. α2 of VP9 was in a completely 
different disposition. The observed structural differences could be partly responsible 






















FIGURE 5.10 Crystal structure vs. NMR mean structure. 
Superimposition of NMR mean structure (red) on crystal monomer structure (blue) of 







5.3.6  Functional implications 
  Based on our results, the dimeric X-ray structure would be biologically 
relevant although the crystal packing forces may shift the monomer-dimer equilibrium, 
thus favoring the formation of the observed dimeric structure. We propose that in fact 
the fast exchange between monomer and dimer in solution may represent a critical 
mechanism to facilitate the conformational switch of VP9 required for the proposed 
DNA binding. 
  The dominant transcriptional regulator of the papillomavirus-1 E2 protein, 
which shares the closest structure homology to VP9, binds to its DNA target through a 
dimeric arrangement of E2. E2/DNA complex has been crystallized (Pdb code 2BOP). 
The bound DNA is severely but smoothly bent over the E2 structure through the 
interactions between the major grooves and a pair of symmetrically disposed α-helices 
of the E2 dimer. The superposition of the VP9 and papillomaviruse-1 E2 bound with 
the DNA fragment reveals a possible DNA binding mode of VP9. The specific DNA 
sequence for recognition by VP9 has not yet been established. A possible DNA 
recognition region is located at the α1 (Thr17-Thr26) and the ß-turn (Ser36-Asp40). 
The helix α1 is highly conserved among all structural homologs of VP9. In the 
superimposed model the side-chains from Arg19 and Lys25 from α1 is facing the 
DNA. Figure 5.11 shows the DNA binding model for VP9. It shows only the 
monomer of VP9 superimposed with the monomer of E2 DNA-binding domain. In E2 
crystal structure the DNA fragment binds with the dimer. However in the case of VP9, 
the superimposed DNA fragment has to undergo a conformational change to engage 
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with both monomers of the dimer. Similar conformational changes upon DNA binding 
were previously documented for several DNA protein complexes (Hedge et al., 1992). 
Although the exact cellular function of VP9 has yet to be demonstrated, our studies 
including the transcriptional, western blot, MS, and immuno-electron microscopy, 
have identified VP9 as a novel, nonstructural and abundant protein in the WSSV 
infected host tissues. The structure of VP9 is the first structure to be reported for 
WSSV proteins. The X-ray and NMR based structural studies revealed that VP9 
possesses a DNA recognition fold with specific metal-binding sites. A possible natural 
metal co-factor could be Zinc ions (Sivaraman et al., 2005). Taken together, we 
speculate that VP9 might be involved in the transcriptional regulation of WSSV 
similar to its most structurally homologous counterpart, the E2 protein in the 
papillomavirus-1. Our findings have identified a new candidate protein suitable for 
















FIGURE 5.11 Proposed DNA binding model. 
Superimposition of E2 monomer (with DNA molecules) on VP9 monomer, DNA is 
shown in stick representation (blue), E2 in ribbon representation (red), VP9 in ribbon 
representation (yellow). α1 of E2 and VP9 highlighted in magenta and cyan 





























6.1  Summary 
 The main aim of this work was structural and functional characterizations of 
a highly abundant nonstructural protein in WSSV, VP9, which has the potential of 
playing an important role in the regulation of gene transcription or translation during 
viral infection. The functional studies of this novel protein have been greatly 
hampered due to the lack of a suitable cell line. In order to facilitate the 
characterization of this functionally important gene, structure-based functional 
analyses were applied using NMR and X-ray crystallography. 
 Despite the exact cellular function of VP9 has yet to be revealed, our studies 
including transcriptional analysis, western blot, MS, and immuno-electron 
microscopy have identified VP9 as a novel, nonstructural and highly abundant protein 
in the WSSV infected host tissues. X-ray crystallography and NMR based structural 
studies revealed that VP9 possesses a DNA recognition fold with specific 
metal-binding sites to Cd2+ or Zn2+ ions. A possible natural metal co-factor could be 
zinc ions (Sivaraman et al., 2005). Taken together, we speculate that VP9 might be 
involved in the transcriptional regulation of WSSV similar to its most structurally 
homologous counterpart, the E2 protein in the papillomavirus-1. Our findings have 
identified a new candidate protein suitable for further studies towards drug and 





6.2 Future studies 
 
6.2.1 Establishment of cell line  
  A complete understanding of shrimp viruses is dependent upon the 
development of laboratory techniques for the maintenance and culturing of these 
viruses and host cells (Hsu et al. 1995). In the case of WSSV, attempts were made by 
various researchers in establishing a primary cell culture and continuous cell lines 
from different organ sources of shrimp (Luedman and Lightner 1992; Purushothaman 
et al. 1998 and Roper et al. 2001). There were no successful attempts on the 
development of a primary cell culture derived from hepatopancreas (Toullec et al., 
1996). As a result, functional studies of WSSV novel genes have been greatly 
hampered (Liu et al., 2006). Consequently, the establishment of a primary or stable 
cell culture becomes urgent and critical. Once such a cell culture system is available, 
scientists will be able to design and conduct more biochemical experiments, and 
ultimately dissect the molecular mechanism of WSSV infections in the near future. 
  
6.2.2 RNAi  
  RNAi has been employed to specifically inhibit gene expression and 
replication of infectious viruses. The replication of a growing number of human 
pathogenic viruses has been shown to be inhibited by RNAi, including poliovirus, 
HIV-1, HCV, influenza virus and hepatitis B virus (Randall et al., 2003). Also, RNAi 
has been revealed to function as an adaptive antiviral immune mechanism (Lu et al., 
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2005; Wilkins et al., 2005). Recently the in vivo roles of double-stranded RNA 
(dsRNA) and RNAi in shrimp antiviral immunity have also been demonstrated 
(Robalino et al., 2004, 2005; Westenberg et al., 2005). In the mean time, 
sequence-independent or sequence-specific dsRNA, which may activate RNAi-like 
mechanisms as antiviral response, was shown to be induced in the marine shrimp, 
Litopenaeus vannamei (Robalino et al., 2004, 2005). It was reported that siRNA could 
suppress the gene expression and replication of WSSV in a sequence-independent 
manner (Westenberg et al., 2005). Recently, RNAi has been applied very effectively 
in Caenorhabditis elegans functional genomics (Lamitina 2006) and others species 
(Zhou et al., 2006). Taken together, we believe that the application of RNAi 
technology will greatly facilitate our understanding to the mechanism of WSSV 
infections. 
 
6.2.3 Structural genomics 
  The main technologies used in structural genomics are X-ray crystallography, 
nuclear magnetic resonance (NMR) spectroscopy and cryo-electron microscopy 
(cryo-EM). 
 CD coupled with NMR-based heteronuclear single-quantum coherence 
(HSQC) experiments can be employed to explore the foldings of all candidate 
proteins in WSSV. The CD spectrum is the simplest and fastest way to differentiate 
well structured proteins from unstructured ones. In addition, more accurate and 
detailed information regarding the folding of a protein can be deduced from 
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NMR-based HSQC experiments. Basically, based on their HSQC spectra, proteins can 
be categorized into two groups: 1) well-structured proteins with well-dispersed HSQC 
spectra and narrow resonance peaks; 2) partially-structured proteins with poorly 
dispersed HSQC spectra and broad resonance peaks. After screening, proteins with 
poor CD and HSQC spectra will be identified as unstructured and therefore will be 
excluded; only well structured proteins will be selected for structure determinations. 
 For structure determination of well-folded proteins, strategies will be chosen 
based on the molecular weight of the protein. Basically, X-ray crystallography will be 
applied for proteins with size larger than 15 kDa, e.g. envelope and capsid proteins. 
Meanwhile, NMR will be utilized for small proteins with size less than 15 kDa. In 
addition, for those functionally important proteins, NMR will be also employed to 
guide the designing of inhibitors or small molecules. The obtained inhibitors and 
small molecules hold a promise to serve as potential templates for further drug design 
(Song and Ni, 1998). 
 Cryo-electron microscopy (cryoEM) can be utilized to study the mechanism 
of the viral particle assembly. For the cryoEM studies, WSSV virions can be prepared 
by rapid plunging into liquid ethane at a temperature of -180 °C and imaged at low 
temperature in the EM at a magnification of 20-50,000 times using minimal dose 
techniques (Dubochet et al., 1988). It is feasible to use such methods to determine the 
overall structure and symmetry of the virion and nucleocapsids. Comparison of the 
virion and nucleocapsid structures will provide insights into the infection, assembly 
and maturation process of the viral particle. Using the available antibodies 
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immuno-EM can be used to determine the location of individual particles in the virus 
particles. With the available X-ray structures of component proteins, these can be 
combined with the overall EM structure to provide a more complete structural 
description. 
 Structural genomics aims to determine the structures of all structured proteins. 
Besides elucidating the functions of the presumptive proteins based on the determined 
structure, such study should provide the essential structural insight for the designing 
of inhibitors or small molecules. Ultimately, drugs can be developed to keep the 
WSSV infection under control and therefore boost the shrimp aquaculture industry. 
 
6.2.4  Structure-based drug design 
  The analysis of protein structure is often performed with one goal in mind: to 
design a ligand capable of binding to it and moderating its activity (Stewart, 2002). 
  Our X-ray and NMR-based structural studies revealed that VP9 possesses a 
DNA recognition fold with specific metal binding sites (coordinating residues include 
Asp9, Glu31, and Cys46). The specific DNA sequence for recognition by VP9 has not 
yet been established. However, based on homology modeling, a possible DNA 
binding region located at α1 (Thr17-Thr26) and the β-turn (Ser36-Asp40) has been 
proposed (Liu et al., 2006). 
  Thus, the metal binding sites, α1 and β-turn form three presumably active 
sites for de novo VP9-structure-based drug design. Algorithms are available to design 
ligands in silico and approach the task in different ways (Bohm, 1992; Gillet et al., 
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1993). Efforts to dock potential chemical groups and subsequently accept those 
groups that appear to bind well to the active site may be attempted; otherwise, we can 
dock a starting group or a substructure, and then add groups to this starting point, 
effectively “evolving” a ligand in the active site. Once identified, crystallization of 
lead structures in the protein target will be performed in order to enable further 
designing (Daniel, 2005). A careful examination of such a co-complex will highlight 
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